{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:42:45Z","timestamp":1793403765733,"version":"4.5.0"},"reference-count":275,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s12015-026-11217-2","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:02:03Z","timestamp":1789113723000},"page":"3586-3612","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rewiring Cellular Context as A Central Mechanism Governing Cancer Stem Cell Survival: Insights from ESC Comparisons"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6721-1775","authenticated-orcid":false,"given":"Yasin","family":"Ahmadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak Elyasi","family":"Far","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9888-7508","authenticated-orcid":false,"given":"Sakhavat","family":"Abolhasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"11217_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/bs.pmbts.2023.02.012","volume":"199","author":"Z Tian","year":"2023","unstructured":"Tian, Z., Yu, T., Liu, J., Wang, T., & Higuchi, A. (2023). Introduction to stem cells. Progress in Molecular Biology and Translational Science, 199, 3\u201332.","journal-title":"Progress in Molecular Biology and Translational Science"},{"key":"11217_CR2","doi-asserted-by":"crossref","unstructured":"Mim, T. J., Ahmad, I., Basher, S. R., Rahman, M. F., Ambati, S. R., Venkatagiri, K., \u2026 Kondaveeti, S. B. (2026). Stem cells in organogenesis and regeneration. Stem Cell Research & Therapy.","DOI":"10.1186\/s13287-025-04889-z"},{"key":"11217_CR3","doi-asserted-by":"publisher","unstructured":"Boyer, L. A., Lee, T. I., Cole, M. F., Johnstone, S. E., Levine, S. S., Zucker, J. P., \u2026 Young, R. A. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell, 122(6), 947\u2013956. https:\/\/doi.org\/10.1016\/j.cell.2005.08.020","DOI":"10.1016\/j.cell.2005.08.020"},{"issue":"2","key":"11217_CR4","first-page":"38","volume":"7","author":"MT Gonz\u00e1lez-Garza","year":"2018","unstructured":"Gonz\u00e1lez-Garza, M. T., Cruz-Vega, D. E., C\u00e1rdenas-Lopez, A., de la Rosa, R. M., & Moreno-Cuevas, J. E. (2018). Comparing stemness gene expression between stem cell subpopulations from peripheral blood and adipose tissue. American Journal of Stem Cells, 7(2), 38.","journal-title":"American Journal of Stem Cells"},{"key":"11217_CR5","doi-asserted-by":"crossref","unstructured":"Chambers, I., Silva, J., Colby, D., Nichols, J., Nijmeijer, B., Robertson, M., \u2026 Smith, A. (2007). Nanog safeguards pluripotency and mediates germline development. Nature, 450(7173), 1230\u20131234.","DOI":"10.1038\/nature06403"},{"key":"11217_CR6","doi-asserted-by":"crossref","unstructured":"Sheinboim, D., Maza, I., Dror, I., Parikh, S., Krupalnik, V., Bell, R. E., \u2026 Mandel-Gutfreund, Y. (2017). OCT4 impedes cell fate redirection by the melanocyte lineage master regulator MITF in mouse ESCs. Nature Communications, 8(1), 1022.","DOI":"10.1038\/s41467-017-01122-1"},{"issue":"7","key":"11217_CR7","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1089\/scd.2009.0113","volume":"18","author":"V Kashyap","year":"2009","unstructured":"Kashyap, V., Rezende, N. C., Scotland, K. B., Shaffer, S. M., Persson, J. L., Gudas, L. J., & Mongan, N. P. (2009). Regulation of Stem Cell Pluripotency and Differentiation Involves a Mutual Regulatory Circuit of the Nanog, OCT4, and SOX2 Pluripotency Transcription Factors With Polycomb Repressive Complexes and Stem Cell microRNAs. Stem Cells and Development, 18(7), 1093\u20131108. https:\/\/doi.org\/10.1089\/scd.2009.0113","journal-title":"Stem Cells and Development"},{"key":"11217_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2015.00161","author":"LM Julian","year":"2015","unstructured":"Julian, L. M., & Blais, A. (2015). Transcriptional control of stem cell fate by E2Fs and pocket proteins. Frontiers in Genetics. https:\/\/doi.org\/10.3389\/fgene.2015.00161","journal-title":"Frontiers in Genetics"},{"issue":"10","key":"11217_CR9","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1007\/s00018-021-03797-8","volume":"78","author":"M ter Huurne","year":"2021","unstructured":"ter Huurne, M., & Stunnenberg, H. G. (2021). G1-phase progression in pluripotent stem cells. Cellular and Molecular Life Sciences, 78(10), 4507\u20134519. https:\/\/doi.org\/10.1007\/s00018-021-03797-8","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"11","key":"11217_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.723137","volume":"2021","author":"D Xie","year":"2021","unstructured":"Xie, D., Pei, Q., Li, J., Wan, X., & Ye, T. (2021). Emerging Role of E2F Family in Cancer Stem Cells. Frontiers in Oncology, 2021(11), Article 723137.","journal-title":"Frontiers in Oncology"},{"issue":"5","key":"11217_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1089\/cell.2017.0015","volume":"19","author":"M Farzaneh","year":"2017","unstructured":"Farzaneh, M., Attari, F., & Khoshnam, S. E. (2017). Concise review: LIN28\/let-7 signaling, a critical double-negative feedback loop during pluripotency, reprogramming, and tumorigenicity. Cellular Reprogramming, 19(5), 289\u2013293. https:\/\/doi.org\/10.1089\/cell.2017.0015","journal-title":"Cellular Reprogramming"},{"key":"11217_CR12","doi-asserted-by":"crossref","unstructured":"Zepeda-Martinez, J. A., Pribitzer, C., Wang, J., Bsteh, D., Golumbeanu, S., Zhao, Q., \u2026 Jude, J. (2020). Parallel PRC2\/cPRC1 and vPRC1 pathways silence lineage-specific genes and maintain self-renewal in mouse embryonic stem cells. Science Advances, 6(14), eaax5692.","DOI":"10.1126\/sciadv.aax5692"},{"issue":"1","key":"11217_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13619-024-00207-9","volume":"13","author":"S Liu","year":"2024","unstructured":"Liu, S., Ren, J., Hu, Y., Zhou, F., & Zhang, L. (2024). TGF\u03b2 family signaling in human stem cell self-renewal and differentiation. Cell Regeneration, 13(1), 26. https:\/\/doi.org\/10.1186\/s13619-024-00207-9","journal-title":"Cell Regeneration"},{"key":"11217_CR14","doi-asserted-by":"publisher","unstructured":"Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., \u2026 Lander, E. S. (2006). A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell, 125(2), 315\u2013326. https:\/\/doi.org\/10.1016\/j.cell.2006.02.041","DOI":"10.1016\/j.cell.2006.02.041"},{"issue":"7","key":"11217_CR15","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrm1938","volume":"7","author":"E Meshorer","year":"2006","unstructured":"Meshorer, E., & Misteli, T. (2006). Chromatin in pluripotent embryonic stem cells and differentiation. Nature Reviews Molecular Cell Biology, 7(7), 540\u2013546. https:\/\/doi.org\/10.1038\/nrm1938","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"11217_CR16","doi-asserted-by":"publisher","unstructured":"Azuara, V., Perry, P., Sauer, S., Spivakov, M., J\u00f8rgensen, H. F., John, R. M., \u2026 Fisher, A. G. (2006). Chromatin signatures of pluripotent cell lines. Nature Cell Biology, 8(5), 532\u2013538. https:\/\/doi.org\/10.1038\/ncb1403","DOI":"10.1038\/ncb1403"},{"key":"11217_CR17","doi-asserted-by":"publisher","unstructured":"Zhang, W., Lou, Y.-R., Zhou, J., & He, Z. (2022). Editorial: stem cells in tissue homeostasis and disease. Frontiers in Cell and Developmental Biology, 10. https:\/\/doi.org\/10.3389\/fcell.2022.876060","DOI":"10.3389\/fcell.2022.876060"},{"key":"11217_CR18","doi-asserted-by":"publisher","unstructured":"Lee, H., Kim, B., Park, J., Park, S., Yoo, G., Yum, S., \u2026 Youn, B. (2025). Cancer stem cells: landscape, challenges and emerging therapeutic innovations. Signal Transduction and Targeted Therapy, 10(1), 248. https:\/\/doi.org\/10.1038\/s41392-025-02360-2","DOI":"10.1038\/s41392-025-02360-2"},{"key":"11217_CR19","doi-asserted-by":"crossref","unstructured":"Chang, C.-H., Liu, F., Militi, S., Hester, S., Nibhani, R., Deng, S., \u2026 Fischer, R. (2024). The pRb\/RBL2-E2F1\/4-GCN5 axis regulates cancer stem cell formation and G0 phase entry\/exit by paracrine mechanisms. Nature Communications, 15(1), 3580.","DOI":"10.1038\/s41467-024-47680-z"},{"issue":"6","key":"11217_CR20","doi-asserted-by":"publisher","first-page":"636","DOI":"10.25259\/IJMR_724_2024","volume":"161","author":"D Sharma","year":"2025","unstructured":"Sharma, D., Gupta, S., Koshy, G., Sharma, V. K., Kamboj, M., & Hooda, A. (2025). Expression profile of cancer stem cell markers SOX2, OCT4 & NANOG in salivary gland malignancies: A systematic review. The Indian Journal of Medical Research, 161(6), 636.","journal-title":"The Indian Journal of Medical Research"},{"key":"11217_CR21","doi-asserted-by":"crossref","unstructured":"Li, J., Chen, Y., Wang, J., Liu, L., Qadir, J., Xie, D., \u2026 Ye, T. (2025). E2F1-autophagy-ALDH1A1 axis enhances self-renewal and drug resistance of lung cancer stem-like cells in a p53-dependent manner. Journal of Experimental & Clinical Cancer Research, 44(1), 261.","DOI":"10.1186\/s13046-025-03506-4"},{"key":"11217_CR22","doi-asserted-by":"crossref","unstructured":"Imran, K., Iqbal, M. J., Ahmed, M. M., Khalid, A., Cort\u00e9s, H., Reyes-Hern\u00e1ndez, O. D., \u2026 Libra, M. (2025). Epigenetic dysregulation in cancer: Mechanisms, diagnostic biomarkers and therapeutic strategies. Medical Oncology, 42(8), 359.","DOI":"10.1007\/s12032-025-02905-z"},{"key":"11217_CR23","doi-asserted-by":"crossref","unstructured":"Ng, C. X., Lee, S. Y., Yap, X. Y., Wong, Y. H., Loh, J. S., Ang, K. P., \u2026 Lee, S. H. (2025). Epigenetic reprogramming as the nexus of cancer stemness and therapy resistance: implications for biomarker discovery. Discover Oncology.","DOI":"10.1007\/s12672-025-04085-8"},{"key":"11217_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117147","volume":"178","author":"M Sun","year":"2024","unstructured":"Sun, M., Ji, Y., Zhang, G., Li, Y., Dong, F., & Wu, T. (2024). Posttranslational modifications of E2F family members in the physiological state and in cancer: Roles, mechanisms and therapeutic targets. Biomedicine & Pharmacotherapy, 178, Article 117147.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"11217_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-026-05014-4","author":"Z Tylichova","year":"2026","unstructured":"Tylichova, Z., Vojtesek, B., & Coates, P. J. (2026). The metabolic profiles of cancer stem cells. Stem Cell Research & Therapy. https:\/\/doi.org\/10.1186\/s13287-026-05014-4","journal-title":"Stem Cell Research & Therapy"},{"issue":"7","key":"11217_CR26","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.jmb.2015.07.019","volume":"428","author":"K Setoguchi","year":"2016","unstructured":"Setoguchi, K., TeSlaa, T., Koehler, C. M., & Teitell, M. A. (2016). P53 regulates rapid apoptosis in human pluripotent stem cells. Journal of Molecular Biology, 428(7), 1465\u20131475.","journal-title":"Journal of Molecular Biology"},{"issue":"5","key":"11217_CR27","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.tcb.2014.03.002","volume":"24","author":"JC Liu","year":"2014","unstructured":"Liu, J. C., Lerou, P. H., & Lahav, G. (2014). Stem cells: Balancing resistance and sensitivity to DNA damage. Trends in Cell Biology, 24(5), 268\u2013274.","journal-title":"Trends in Cell Biology"},{"key":"11217_CR28","doi-asserted-by":"publisher","unstructured":"Liu, J. C., Guan, X., Ryan, J. A., Rivera, A. G., Mock, C., Agarwal, V., \u2026 Lahav, G. (2013). High Mitochondrial Priming Sensitizes hESCs to DNA-Damage-Induced Apoptosis. Cell Stem Cell, 13(4), 483\u2013491. https:\/\/doi.org\/10.1016\/j.stem.2013.07.018","DOI":"10.1016\/j.stem.2013.07.018"},{"issue":"7","key":"11217_CR29","first-page":"731","volume":"6","author":"DG Johnson","year":"2006","unstructured":"Johnson, D. G., & DeGregori, J. (2006). Putting the oncogenic and tumor suppressive activities of E2F into context. Current Molecular Medicine, 6(7), 731\u2013738.","journal-title":"Current Molecular Medicine"},{"issue":"11","key":"11217_CR30","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.tcb.2008.08.003","volume":"18","author":"S Polager","year":"2008","unstructured":"Polager, S., & Ginsberg, D. (2008). E2F\u2013at the crossroads of life and death. Trends in Cell Biology, 18(11), 528\u2013535.","journal-title":"Trends in Cell Biology"},{"issue":"4","key":"11217_CR31","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1091\/mbc.e04-12-1056","volume":"16","author":"J White","year":"2005","unstructured":"White, J., Stead, E., Faast, R., Conn, S., Cartwright, P., & Dalton, S. (2005). Developmental activation of the Rb\u2013E2F pathway and establishment of cell cycle-regulated cyclin-dependent kinase activity during embryonic stem cell differentiation. Molecular Biology of the Cell, 16(4), 2018\u20132027. https:\/\/doi.org\/10.1091\/mbc.e04-12-1056","journal-title":"Molecular Biology of the Cell"},{"issue":"8","key":"11217_CR32","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1038\/sj.cdd.4402136","volume":"14","author":"WP Roos","year":"2007","unstructured":"Roos, W. P., Christmann, M., Fraser, S. T., & Kaina, B. (2007). Mouse embryonic stem cells are hypersensitive to apoptosis triggered by the DNA damage O6-methylguanine due to high E2F1 regulated mismatch repair. Cell Death & Differentiation, 14(8), 1422\u20131432.","journal-title":"Cell Death & Differentiation"},{"key":"11217_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.672612","volume":"11","author":"M Xie","year":"2021","unstructured":"Xie, M., Xu, X., & Fan, Y. (2021). KRAS-mutant non-small cell lung cancer: An emerging promisingly treatable subgroup. Frontiers in Oncology, 11, Article 672612.","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"11217_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0092-8674(00)81692-X","volume":"100","author":"IL Weissman","year":"2000","unstructured":"Weissman, I. L. (2000). Stem cells. Cell, 100(1), 157\u2013168. https:\/\/doi.org\/10.1016\/S0092-8674(00)81692-X","journal-title":"Cell"},{"issue":"1","key":"11217_CR35","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1146\/annurev-biochem-062917-012341","volume":"87","author":"H Clevers","year":"2018","unstructured":"Clevers, H., & Watt, F. M. (2018). Defining adult stem cells by function, not by phenotype. Annual Review of Biochemistry, 87(1), 1015\u20131027. https:\/\/doi.org\/10.1146\/annurev-biochem-062917-012341","journal-title":"Annual Review of Biochemistry"},{"issue":"5819","key":"11217_CR36","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/292154a0","volume":"292","author":"MJ Evans","year":"1981","unstructured":"Evans, M. J., & Kaufman, M. H. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature, 292(5819), 154\u2013156. https:\/\/doi.org\/10.1038\/292154a0","journal-title":"Nature"},{"issue":"5391","key":"11217_CR37","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282(5391), 1145\u20131147. https:\/\/doi.org\/10.1126\/science.282.5391.1145","journal-title":"Science"},{"issue":"6","key":"11217_CR38","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/ncb2965","volume":"16","author":"T Boroviak","year":"2014","unstructured":"Boroviak, T., Loos, R., Bertone, P., Smith, A., & Nichols, J. (2014). The ability of inner-cell-mass cells to self-renew as embryonic stem cells is acquired following epiblast specification. Nature Cell Biology, 16(6), 513\u2013525. https:\/\/doi.org\/10.1038\/ncb2965","journal-title":"Nature Cell Biology"},{"issue":"1","key":"11217_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/jcp.21925","volume":"222","author":"KA Becker","year":"2010","unstructured":"Becker, K. A., Stein, J. L., Lian, J. B., van Wijnen, A. J., & Stein, G. S. (2010). Human embryonic stem cells are pre-mitotically committed to self-renewal and acquire a lengthened G1 phase upon lineage programming. Journal of Cellular Physiology, 222(1), 103\u2013110. https:\/\/doi.org\/10.1002\/jcp.21925","journal-title":"Journal of Cellular Physiology"},{"issue":"9","key":"11217_CR40","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/s41556-019-0384-4","volume":"21","author":"L Liu","year":"2019","unstructured":"Liu, L., Michowski, W., Kolodziejczyk, A., & Sicinski, P. (2019). The cell cycle in stem cell proliferation, pluripotency and differentiation. Nature Cell Biology, 21(9), 1060\u20131067. https:\/\/doi.org\/10.1038\/s41556-019-0384-4","journal-title":"Nature Cell Biology"},{"issue":"3","key":"11217_CR41","doi-asserted-by":"publisher","first-page":"329","DOI":"10.18388\/abp.2015_1023","volume":"62","author":"J Dulak","year":"2015","unstructured":"Dulak, J., Szade, K., Szade, A., Nowak, W., & J\u00f3zkowicz, A. (2015). Adult stem cells: Hopes and hypes of regenerative medicine. Acta Biochimica Polonica, 62(3), 329\u2013337. https:\/\/doi.org\/10.18388\/abp.2015_1023","journal-title":"Acta Biochimica Polonica"},{"issue":"24","key":"11217_CR42","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1242\/dev.106575","volume":"141","author":"A Nakamura-Ishizu","year":"2014","unstructured":"Nakamura-Ishizu, A., Takizawa, H., & Suda, T. (2014). The analysis, roles and regulation of quiescence in hematopoietic stem cells. Development, 141(24), 4656\u20134666. https:\/\/doi.org\/10.1242\/dev.106575","journal-title":"Development"},{"issue":"5","key":"11217_CR43","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41580-022-00568-6","volume":"24","author":"A de Morree","year":"2023","unstructured":"de Morree, A., & Rando, T. A. (2023). Regulation of adult stem cell quiescence and its functions in the maintenance of tissue integrity. Nature Reviews Molecular Cell Biology, 24(5), 334\u2013354. https:\/\/doi.org\/10.1038\/s41580-022-00568-6","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"7097","key":"11217_CR44","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/nature04956","volume":"441","author":"SJ Morrison","year":"2006","unstructured":"Morrison, S. J., & Kimble, J. (2006). Asymmetric and symmetric stem-cell divisions in development and cancer. Nature, 441(7097), 1068\u20131074. https:\/\/doi.org\/10.1038\/nature04956","journal-title":"Nature"},{"issue":"4","key":"11217_CR45","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.cell.2008.02.007","volume":"132","author":"JA Knoblich","year":"2008","unstructured":"Knoblich, J. A. (2008). Mechanisms of Asymmetric Stem Cell Division. Cell, 132(4), 583\u2013597. https:\/\/doi.org\/10.1016\/j.cell.2008.02.007","journal-title":"Cell"},{"key":"11217_CR46","doi-asserted-by":"publisher","unstructured":"Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., \u2026 Daley, G. Q. (2010). Epigenetic memory in induced pluripotent stem cells. Nature, 467(7313), 285\u2013290. https:\/\/doi.org\/10.1038\/nature09342","DOI":"10.1038\/nature09342"},{"key":"11217_CR47","doi-asserted-by":"publisher","unstructured":"Polo, J. M., Liu, S., Figueroa, M. E., Kulalert, W., Eminli, S., Tan, K. Y., \u2026 Hochedlinger, K. (2010). Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nature Biotechnology, 28(8), 848\u2013855. https:\/\/doi.org\/10.1038\/nbt.1667","DOI":"10.1038\/nbt.1667"},{"issue":"6","key":"11217_CR48","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1101\/gad.1876710","volume":"24","author":"MJ Edel","year":"2010","unstructured":"Edel, M. J., Menchon, C., Menendez, S., Consiglio, A., Raya, A., & Izpisua Belmonte, J. C. (2010). Rem2 GTPase maintains survival of human embryonic stem cells as well as enhancing reprogramming by regulating p53 and cyclin D 1. Genes & Development, 24(6), 561\u2013573. https:\/\/doi.org\/10.1101\/gad.1876710","journal-title":"Genes & Development"},{"issue":"2","key":"11217_CR49","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1385\/SCR:1:2:131","volume":"1","author":"J White","year":"2005","unstructured":"White, J., & Dalton, S. (2005). Cell cycle control of embryonic stem cells. Stem Cell Reviews, 1(2), 131\u2013138. https:\/\/doi.org\/10.1385\/SCR:1:2:131","journal-title":"Stem Cell Reviews"},{"issue":"5965","key":"11217_CR50","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1126\/science.1180794","volume":"327","author":"L Li","year":"2010","unstructured":"Li, L., & Clevers, H. (2010). Coexistence of Quiescent and Active Adult Stem Cells in Mammals. Science, 327(5965), 542\u2013545. https:\/\/doi.org\/10.1126\/science.1180794","journal-title":"Science"},{"key":"11217_CR51","doi-asserted-by":"publisher","unstructured":"Wilson, A., Laurenti, E., Oser, G., van der Wath, R. C., Blanco-Bose, W., Jaworski, M., \u2026 Trumpp, A. (2008). Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell, 135(6), 1118\u20131129. https:\/\/doi.org\/10.1016\/j.cell.2008.10.048","DOI":"10.1016\/j.cell.2008.10.048"},{"key":"11217_CR52","doi-asserted-by":"publisher","unstructured":"Hanna, J., Markoulaki, S., Schorderet, P., Carey, B. W., Beard, C., Wernig, M., \u2026 Jaenisch, R. (2008). Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell, 133(2), 250\u2013264. https:\/\/doi.org\/10.1016\/j.cell.2008.03.028","DOI":"10.1016\/j.cell.2008.03.028"},{"issue":"7412","key":"11217_CR53","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nature11287","volume":"488","author":"J Chen","year":"2012","unstructured":"Chen, J., Li, Y., Yu, T.-S., McKay, R. M., Burns, D. K., Kernie, S. G., & Parada, L. F. (2012). A restricted cell population propagates glioblastoma growth after chemotherapy. Nature, 488(7412), 522\u2013526. https:\/\/doi.org\/10.1038\/nature11287","journal-title":"Nature"},{"issue":"1","key":"11217_CR54","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s11033-025-10351-3","volume":"52","author":"Y Ahmadi","year":"2025","unstructured":"Ahmadi, Y., Faiq, T., & Abolhasani, S. (2025). Impact of G1 phase kinetics on the acquisition of stemness in cancer cells: The critical role of cyclin D. Molecular Biology Reports, 52(1), 230. https:\/\/doi.org\/10.1007\/s11033-025-10351-3","journal-title":"Molecular Biology Reports"},{"key":"11217_CR55","doi-asserted-by":"publisher","unstructured":"Ruiz, S., Panopoulos, A. D., Herrer\u00edas, A., Bissig, K.-D., Lutz, M., Berggren, W. T., \u2026 Izpisua Belmonte, J. C. (2011). A high proliferation rate is required for cell reprogramming and maintenance of human embryonic stem cell identity. Current Biology, 21(1), 45\u201352. https:\/\/doi.org\/10.1016\/j.cub.2010.11.049","DOI":"10.1016\/j.cub.2010.11.049"},{"issue":"22","key":"11217_CR56","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1242\/jcs.074120","volume":"124","author":"S Pauklin","year":"2011","unstructured":"Pauklin, S., Pedersen, R. A., & Vallier, L. (2011). Mouse pluripotent stem cells at a glance. Journal of Cell Science, 124(22), 3727\u20133732. https:\/\/doi.org\/10.1242\/jcs.074120","journal-title":"Journal of Cell Science"},{"issue":"4","key":"11217_CR57","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1093\/nsr\/nwx093","volume":"4","author":"G Peng","year":"2017","unstructured":"Peng, G., Tam, P. P. L., & Jing, N. (2017). Lineage specification of early embryos and embryonic stem cells at the dawn of enabling technologies. National Science Review, 4(4), 533\u2013542. https:\/\/doi.org\/10.1093\/nsr\/nwx093","journal-title":"National Science Review"},{"issue":"5","key":"11217_CR58","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1080\/19491034.2016.1248013","volume":"7","author":"C Lopes Novo","year":"2016","unstructured":"Lopes Novo, C., & Rugg-Gunn, P. (2016). Crosstalk between pluripotency factors and higher-order chromatin organization. Nucleus, 7(5), 447\u2013452.","journal-title":"Nucleus"},{"key":"11217_CR59","doi-asserted-by":"crossref","unstructured":"Gaspar-Maia, A., Alajem, A., Polesso, F., Sridharan, R., Mason, M. J., Heidersbach, A., \u2026 Meshorer, E. (2009). Chd1 regulates open chromatin and pluripotency of embryonic stem cells. Nature, 460(7257), 863\u2013868.","DOI":"10.1038\/nature08212"},{"issue":"1","key":"11217_CR60","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nrm3036","volume":"12","author":"A Gaspar-Maia","year":"2011","unstructured":"Gaspar-Maia, A., Alajem, A., Meshorer, E., & Ramalho-Santos, M. (2011). Open chromatin in pluripotency and reprogramming. Nature Reviews Molecular Cell Biology, 12(1), 36\u201347. https:\/\/doi.org\/10.1038\/nrm3036","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"6","key":"11217_CR61","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1101\/gad.1642408","volume":"22","author":"MF Cole","year":"2008","unstructured":"Cole, M. F., Johnstone, S. E., Newman, J. J., Kagey, M. H., & Young, R. A. (2008). Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells. Genes & development, 22(6), 746\u2013755.","journal-title":"Genes & development"},{"issue":"7","key":"11217_CR62","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1002\/stem.1705","volume":"32","author":"F Fang","year":"2014","unstructured":"Fang, F., Xu, Y., Chew, K.-K., Chen, X., Ng, H.-H., & Matsudaira, P. (2014). Coactivators p300 and CBP maintain the identity of mouse embryonic stem cells by mediating long-range chromatin structure. Stem Cells, 32(7), 1805\u20131816.","journal-title":"Stem Cells"},{"key":"11217_CR63","doi-asserted-by":"crossref","unstructured":"Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., \u2026 Plath, K. (2006). A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell, 125(2), 315\u2013326.","DOI":"10.1016\/j.cell.2006.02.041"},{"issue":"1","key":"11217_CR64","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41580-022-00518-2","volume":"24","author":"TA Macrae","year":"2023","unstructured":"Macrae, T. A., Fothergill-Robinson, J., & Ramalho-Santos, M. (2023). Regulation, functions and transmission of bivalent chromatin during mammalian development. Nature reviews Molecular cell biology, 24(1), 6\u201326.","journal-title":"Nature reviews Molecular cell biology"},{"key":"11217_CR65","doi-asserted-by":"crossref","unstructured":"Mannino, G., Russo, C., Maugeri, G., Musumeci, G., Vicario, N., Tibullo, D., \u2026 Lo Furno, D. (2022). Adult stem cell niches for tissue homeostasis. Journal of Cellular Physiology, 237(1), 239\u2013257.","DOI":"10.1002\/jcp.30562"},{"key":"11217_CR66","doi-asserted-by":"publisher","unstructured":"Rezza, A., Sennett, R., & Rendl, M. (2014). Adult Stem Cell Niches (pp. 333\u2013372). https:\/\/doi.org\/10.1016\/B978-0-12-416022-4.00012-3","DOI":"10.1016\/B978-0-12-416022-4.00012-3"},{"issue":"1","key":"11217_CR67","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrm2319","volume":"9","author":"DL Jones","year":"2008","unstructured":"Jones, D. L., & Wagers, A. J. (2008). No place like home: Anatomy and function of the stem cell niche. Nature Reviews Molecular Cell Biology, 9(1), 11\u201321. https:\/\/doi.org\/10.1038\/nrm2319","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"11217_CR68","doi-asserted-by":"publisher","unstructured":"Ma, Z., Tan, S., Lu, R., Chen, P., Hu, Y., Yang, T., \u2026 Ye, Y. (2025). Interplay of chromatin remodeling BAF complexes in mouse embryonic and epiblast stem cell conversion and maintenance. Journal of Biological Chemistry, 301(2), 108140. https:\/\/doi.org\/10.1016\/j.jbc.2024.108140","DOI":"10.1016\/j.jbc.2024.108140"},{"issue":"1","key":"11217_CR69","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13287-023-03316-5","volume":"14","author":"X Tang","year":"2023","unstructured":"Tang, X., Wang, Z., Wang, J., Cui, S., Xu, R., & Wang, Y. (2023). Functions and regulatory mechanisms of resting hematopoietic stem cells: A promising targeted therapeutic strategy. Stem Cell Research & Therapy, 14(1), 73. https:\/\/doi.org\/10.1186\/s13287-023-03316-5","journal-title":"Stem Cell Research & Therapy"},{"issue":"9","key":"11217_CR70","doi-asserted-by":"publisher","first-page":"8386","DOI":"10.3390\/ijms24098386","volume":"24","author":"F Varzideh","year":"2023","unstructured":"Varzideh, F., Gambardella, J., Kansakar, U., Jankauskas, S. S., & Santulli, G. (2023). Molecular mechanisms underlying pluripotency and self-renewal of embryonic stem cells. International Journal of Molecular Sciences, 24(9), 8386. https:\/\/doi.org\/10.3390\/ijms24098386","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"11217_CR71","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2217\/17460751.1.3.317","volume":"1","author":"H Darr","year":"2006","unstructured":"Darr, H., & Benvenisty, N. (2006). Human embryonic stem cells: The battle between self-renewal and differentiation. Regenerative Medicine, 1(3), 317\u2013325. https:\/\/doi.org\/10.2217\/17460751.1.3.317","journal-title":"Regenerative Medicine"},{"issue":"11","key":"11217_CR72","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/nrm1744","volume":"6","author":"M Boiani","year":"2005","unstructured":"Boiani, M., & Sch\u00f6ler, H. R. (2005). Regulatory networks in embryo-derived pluripotent stem cells. Nature Reviews Molecular Cell Biology, 6(11), 872\u2013881. https:\/\/doi.org\/10.1038\/nrm1744","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"7","key":"11217_CR73","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-021-01524-8","volume":"38","author":"JR Lim","year":"2021","unstructured":"Lim, J. R., Mouawad, J., Gorton, O. K., Bubb, W. A., & Kwan, A. H. (2021). Cancer stem cell characteristics and their potential as therapeutic targets. Medical Oncology, 38(7), Article 76.","journal-title":"Medical Oncology"},{"key":"11217_CR74","doi-asserted-by":"crossref","unstructured":"Self-Renewal, E. S. C. (2004). Mechanisms of stem cell self-renewal.","DOI":"10.1016\/B978-012436643-5\/50013-4"},{"issue":"1","key":"11217_CR75","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/embor.2012.197","volume":"14","author":"E Fuchs","year":"2013","unstructured":"Fuchs, E., & Chen, T. (2013). A matter of life and death: Self-renewal in stem cells. EMBO Reports, 14(1), 39\u201348.","journal-title":"EMBO Reports"},{"key":"11217_CR76","doi-asserted-by":"publisher","unstructured":"Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., \u2026 Cui, H. (2020). Targeting cancer stem cell pathways for cancer therapy. Signal Transduction and Targeted Therapy, 5(1), 8. https:\/\/doi.org\/10.1038\/s41392-020-0110-5","DOI":"10.1038\/s41392-020-0110-5"},{"issue":"1","key":"11217_CR77","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12943-017-0600-4","volume":"16","author":"PR Prasetyanti","year":"2017","unstructured":"Prasetyanti, P. R., & Medema, J. P. (2017). Intra-tumor heterogeneity from a cancer stem cell perspective. Molecular Cancer, 16(1), 41. https:\/\/doi.org\/10.1186\/s12943-017-0600-4","journal-title":"Molecular Cancer"},{"key":"11217_CR78","doi-asserted-by":"publisher","unstructured":"Osum, M., & Kalkan, R. (2023). Cancer Stem Cells and Their Therapeutic Usage (pp. 69\u201385). https:\/\/doi.org\/10.1007\/5584_2022_758","DOI":"10.1007\/5584_2022_758"},{"key":"11217_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/396076","volume":"2011","author":"N Moore","year":"2011","unstructured":"Moore, N., & Lyle, S. (2011). Quiescent, slow-cycling stem cell populations in cancer: A review of the evidence and discussion of significance. Journal of Oncology, 2011, 1\u201311. https:\/\/doi.org\/10.1155\/2011\/396076","journal-title":"Journal of Oncology"},{"key":"11217_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107985","volume":"231","author":"R Paul","year":"2022","unstructured":"Paul, R., Dorsey, J. F., & Fan, Y. (2022). Cell plasticity, senescence, and quiescence in cancer stem cells: Biological and therapeutic implications. Pharmacology & Therapeutics, 231, Article 107985. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107985","journal-title":"Pharmacology & Therapeutics"},{"issue":"7123","key":"11217_CR81","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature05372","volume":"445","author":"CA O\u2019Brien","year":"2007","unstructured":"O\u2019Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 445(7123), 106\u2013110. https:\/\/doi.org\/10.1038\/nature05372","journal-title":"Nature"},{"issue":"7","key":"11217_CR82","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003). Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America, 100(7), 3983\u20133988. https:\/\/doi.org\/10.1073\/pnas.0530291100","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"11217_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9971","volume":"6","author":"D Aran","year":"2015","unstructured":"Aran, D., Sirota, M., & Butte, A. J. (2015). Systematic pan-cancer analysis of tumour purity. Nature Communications, 6(1), Article 8971. https:\/\/doi.org\/10.1038\/ncomms9971","journal-title":"Nature Communications"},{"key":"11217_CR84","doi-asserted-by":"publisher","unstructured":"Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., \u2026 Rich, J. N. (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 444(7120), 756\u2013760. https:\/\/doi.org\/10.1038\/nature05236","DOI":"10.1038\/nature05236"},{"key":"11217_CR85","doi-asserted-by":"publisher","unstructured":"Sanai, N., Nguyen, T., Ihrie, R. A., Mirzadeh, Z., Tsai, H.-H., Wong, M., \u2026 Alvarez-Buylla, A. (2011). Corridors of migrating neurons in the human brain and their decline during infancy. Nature, 478(7369), 382\u2013386. https:\/\/doi.org\/10.1038\/nature10487","DOI":"10.1038\/nature10487"},{"key":"11217_CR86","doi-asserted-by":"publisher","unstructured":"Krivtsov, A. V., Twomey, D., Feng, Z., Stubbs, M. C., Wang, Y., Faber, J., \u2026 Armstrong, S. A. (2006). Transformation from committed progenitor to leukaemia stem cell initiated by MLL\u2013AF9. Nature, 442(7104), 818\u2013822. https:\/\/doi.org\/10.1038\/nature04980","DOI":"10.1038\/nature04980"},{"key":"11217_CR87","doi-asserted-by":"publisher","unstructured":"Kopp, J. L., von\u00a0Figura, G., Mayes, E., Liu, F.-F., Dubois, C. L., Morris, J. P., \u2026 Sander, M. (2012). Identification of sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Cancer Cell, 22(6), 737\u2013750. https:\/\/doi.org\/10.1016\/j.ccr.2012.10.025","DOI":"10.1016\/j.ccr.2012.10.025"},{"key":"11217_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/9653244","volume":"2022","author":"S Bisht","year":"2022","unstructured":"Bisht, S., Nigam, M., Kunjwal, S. S., Sergey, P., Mishra, A. P., & Sharifi-Rad, J. (2022). Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting. Stem Cells International, 2022, 1\u201328. https:\/\/doi.org\/10.1155\/2022\/9653244","journal-title":"Stem Cells International"},{"issue":"S1","key":"11217_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-15-S1-S1","volume":"15","author":"SS Franco","year":"2015","unstructured":"Franco, S. S., Raveh-Amit, H., Kobol\u00e1k, J., Alqahtani, M. H., Mobasheri, A., & Dinnyes, A. (2015). The crossroads between cancer stem cells and aging. BMC Cancer, 15(S1), Article S1. https:\/\/doi.org\/10.1186\/1471-2407-15-S1-S1","journal-title":"BMC Cancer"},{"key":"11217_CR90","doi-asserted-by":"publisher","unstructured":"van Neerven, S. M., de Groot, N. E., Nijman, L. E., Scicluna, B. P., van Driel, M. S., Lecca, M. C., \u2026 Vermeulen, L. (2021). Apc-mutant cells act as supercompetitors in intestinal tumour initiation. Nature, 594(7863), 436\u2013441. https:\/\/doi.org\/10.1038\/s41586-021-03558-4","DOI":"10.1038\/s41586-021-03558-4"},{"key":"11217_CR91","doi-asserted-by":"publisher","unstructured":"Barker, N., Ridgway, R. A., van Es, J. H., van de Wetering, M., Begthel, H., van den Born, M., \u2026 Clevers, H. (2009). Crypt stem cells as the cells-of-origin of intestinal cancer. Nature, 457(7229), 608\u2013611. https:\/\/doi.org\/10.1038\/nature07602","DOI":"10.1038\/nature07602"},{"issue":"1","key":"11217_CR92","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","volume":"13","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., & Wang, X. (2020). Targeting the Wnt\/\u03b2-catenin signaling pathway in cancer. Journal of Hematology & Oncology, 13(1), 165. https:\/\/doi.org\/10.1186\/s13045-020-00990-3","journal-title":"Journal of Hematology & Oncology"},{"issue":"6095","key":"11217_CR93","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1126\/science.1224676","volume":"337","author":"AG Schepers","year":"2012","unstructured":"Schepers, A. G., Snippert, H. J., Stange, D. E., van den Born, M., van Es, J. H., van de Wetering, M., & Clevers, H. (2012). Lineage Tracing Reveals Lgr5 + Stem Cell Activity in Mouse Intestinal Adenomas. Science, 337(6095), 730\u2013735. https:\/\/doi.org\/10.1126\/science.1224676","journal-title":"Science"},{"key":"11217_CR94","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt373","author":"B-S Moon","year":"2014","unstructured":"Moon, B.-S., Jeong, W.-J., Park, J., Kim, T. I., Min, D. S., & Choi, K.-Y. (2014). Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt\/\u03b2-catenin signaling. Journal of the National Cancer Institute. https:\/\/doi.org\/10.1093\/jnci\/djt373","journal-title":"Journal of the National Cancer Institute"},{"issue":"3","key":"11217_CR95","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","volume":"137","author":"KH Vousden","year":"2009","unstructured":"Vousden, K. H., & Prives, C. (2009). Blinded by the Light: The Growing Complexity of p53. Cell, 137(3), 413\u2013431. https:\/\/doi.org\/10.1016\/j.cell.2009.04.037","journal-title":"Cell"},{"issue":"1","key":"11217_CR96","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/stem.552","volume":"29","author":"L Tao","year":"2011","unstructured":"Tao, L., Roberts, A. L., Dunphy, K. A., Bigelow, C., Yan, H., & Jerry, D. J. (2011). Repression of mammary stem\/progenitor cells by p53 is mediated by notch and separable from apoptotic activity. Stem Cells, 29(1), 119\u2013127. https:\/\/doi.org\/10.1002\/stem.552","journal-title":"Stem Cells"},{"issue":"13","key":"11217_CR97","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1101\/gad.1940710","volume":"24","author":"Z Zhao","year":"2010","unstructured":"Zhao, Z., Zuber, J., Diaz-Flores, E., Lintault, L., Kogan, S. C., Shannon, K., & Lowe, S. W. (2010). p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewal. Genes & Development, 24(13), 1389\u20131402. https:\/\/doi.org\/10.1101\/gad.1940710","journal-title":"Genes & Development"},{"issue":"4","key":"11217_CR98","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s12079-023-00793-4","volume":"17","author":"E Alvarado-Ortiz","year":"2023","unstructured":"Alvarado-Ortiz, E., Ortiz-S\u00e1nchez, E., Sarabia-S\u00e1nchez, M. A., de la Cruz-L\u00f3pez, K. G., Garc\u00eda-Carranc\u00e1, A., & Robles-Flores, M. (2023). Mutant p53 gain-of-function stimulates canonical Wnt signaling via PI3K\/AKT pathway in colon cancer. Journal of Cell Communication and Signaling, 17(4), 1389\u20131403. https:\/\/doi.org\/10.1007\/s12079-023-00793-4","journal-title":"Journal of Cell Communication and Signaling"},{"key":"11217_CR99","doi-asserted-by":"publisher","unstructured":"Liu, S., Cong, Y., Wang, D., Sun, Y., Deng, L., Liu, Y., \u2026 Wicha, M. S. (2014). Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts. Stem Cell Reports, 2(1), 78\u201391. https:\/\/doi.org\/10.1016\/j.stemcr.2013.11.009","DOI":"10.1016\/j.stemcr.2013.11.009"},{"key":"11217_CR100","doi-asserted-by":"publisher","unstructured":"Cunha, A. F., Delou, J. M., Barbosa, P. S., Concei\u00e7\u00e3o, J. S. M., Souza, K. C. S., Chagas, V., \u2026 Borges, H. L. (2024). Trp53 deletion promotes exacerbated colitis, facilitates Lgr5+ cancer stem cell expansion, and fuels tumorigenesis in AOM\/DSS-induced colorectal cancer. International Journal of Molecular Sciences, 25(20), 10953. https:\/\/doi.org\/10.3390\/ijms252010953","DOI":"10.3390\/ijms252010953"},{"key":"11217_CR101","doi-asserted-by":"publisher","unstructured":"Zhao, Y., Li, Y., Sheng, J., Wu, F., Li, K., Huang, R., \u2026 Song, W. (2019). P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs. Journal of Experimental & Clinical Cancer Research, 38(1), 379. https:\/\/doi.org\/10.1186\/s13046-019-1375-9","DOI":"10.1186\/s13046-019-1375-9"},{"key":"11217_CR102","doi-asserted-by":"publisher","unstructured":"Pathania, R., Ramachandran, S., Elangovan, S., Padia, R., Yang, P., Cinghu, S., \u2026 Thangaraju, M. (2015). DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesis. Nature Communications, 6(1), 6910. https:\/\/doi.org\/10.1038\/ncomms7910","DOI":"10.1038\/ncomms7910"},{"key":"11217_CR103","doi-asserted-by":"publisher","unstructured":"Li, S., Han, Z., Zhao, N., Zhu, B., Zhang, Q., Yang, X., \u2026 Zhang, L. (2018). Inhibition of DNMT suppresses the stemness of colorectal cancer cells through down-regulating Wnt signaling pathway. Cellular Signalling, 47, 79\u201387. https:\/\/doi.org\/10.1016\/j.cellsig.2018.03.014","DOI":"10.1016\/j.cellsig.2018.03.014"},{"key":"11217_CR104","doi-asserted-by":"publisher","unstructured":"Gonzalez, M. E., Moore, H. M., Li, X., Toy, K. A., Huang, W., Sabel, M. S., \u2026 Kleer, C. G. (2014). EZH2 expands breast stem cells through activation of NOTCH1 signaling. Proceedings of the National Academy of Sciences, 111(8), 3098\u20133103. https:\/\/doi.org\/10.1073\/pnas.1308953111","DOI":"10.1073\/pnas.1308953111"},{"key":"11217_CR105","doi-asserted-by":"publisher","unstructured":"Yu, T., Wang, Y., Hu, Q., Wu, W., Wu, Y., Wei, W., \u2026 Liu, N. (2017). The EZH2 inhibitor GSK343 suppresses cancer stem-like phenotypes and reverses mesenchymal transition in glioma cells. Oncotarget, 8(58), 98348\u201398359. https:\/\/doi.org\/10.18632\/oncotarget.21311","DOI":"10.18632\/oncotarget.21311"},{"key":"11217_CR106","doi-asserted-by":"publisher","unstructured":"Song, X., Gao, T., Wang, N., Feng, Q., You, X., Ye, T., \u2026 Yu, L. (2016). Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer. Scientific Reports, 6(1), 20864. https:\/\/doi.org\/10.1038\/srep20864","DOI":"10.1038\/srep20864"},{"key":"11217_CR107","doi-asserted-by":"publisher","unstructured":"Liu, L., Massey, E. J., Zuo, D., Pacis, A., Demirdizen, M., Podleszanski, E., \u2026 Muller, W. J. (2026). EZH2 directs HER2+ breast cancer progression through the modulation of epithelial plasticity. EMBO Reports, 27(5), 1180\u20131208. https:\/\/doi.org\/10.1038\/s44319-026-00691-x","DOI":"10.1038\/s44319-026-00691-x"},{"key":"11217_CR108","doi-asserted-by":"publisher","unstructured":"Park, I., Qian, D., Kiel, M., Becker, M. W., Pihalja, M., Weissman, I. L., \u2026 Clarke, M. F. (2003). Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature, 423(6937), 302\u2013305. https:\/\/doi.org\/10.1038\/nature01587","DOI":"10.1038\/nature01587"},{"issue":"6937","key":"11217_CR109","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature01572","volume":"423","author":"J Lessard","year":"2003","unstructured":"Lessard, J., & Sauvageau, G. (2003). Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature, 423(6937), 255\u2013260. https:\/\/doi.org\/10.1038\/nature01572","journal-title":"Nature"},{"key":"11217_CR110","doi-asserted-by":"publisher","unstructured":"Yan, X.-J., Xu, J., Gu, Z.-H., Pan, C.-M., Lu, G., Shen, Y., \u2026 Chen, S.-J. (2011). Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nature Genetics, 43(4), 309\u2013315. https:\/\/doi.org\/10.1038\/ng.788","DOI":"10.1038\/ng.788"},{"key":"11217_CR111","doi-asserted-by":"publisher","unstructured":"Shlush, L. I., Zandi, S., Mitchell, A., Chen, W. C., Brandwein, J. M., Gupta, V., \u2026 Dick, J. E. (2014). Correction: Corrigendum: Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature, 508(7496), 420\u2013420. https:\/\/doi.org\/10.1038\/nature13190","DOI":"10.1038\/nature13190"},{"issue":"1","key":"11217_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40776-y","volume":"14","author":"RK Bahia","year":"2023","unstructured":"Bahia, R. K., Hao, X., Hassam, R., Cseh, O., Bozek, D. A., Luchman, H. A., & Weiss, S. (2023). Epigenetic and molecular coordination between HDAC2 and SMAD3-SKI regulates essential brain tumour stem cell characteristics. Nature Communications, 14(1), Article 5051. https:\/\/doi.org\/10.1038\/s41467-023-40776-y","journal-title":"Nature Communications"},{"issue":"5","key":"11217_CR113","doi-asserted-by":"publisher","first-page":"4756","DOI":"10.3390\/ijms24054756","volume":"24","author":"M Xu","year":"2023","unstructured":"Xu, M., Zhang, J., Lu, X., Liu, F., Shi, S., & Deng, X. (2023). MiR-199a-5p-Regulated SMARCA4 Promotes Oral Squamous Cell Carcinoma Tumorigenesis. International Journal of Molecular Sciences, 24(5), 4756. https:\/\/doi.org\/10.3390\/ijms24054756","journal-title":"International Journal of Molecular Sciences"},{"key":"11217_CR114","doi-asserted-by":"publisher","unstructured":"Taube, J. H., Sphyris, N., Johnson, K. S., Reisenauer, K. N., Nesbit, T. A., Joseph, R., \u2026 Mani, S. A. (2017). The H3K27me3-demethylase KDM6A is suppressed in breast cancer stem-like cells, and enables the resolution of bivalency during the mesenchymal-epithelial transition. Oncotarget, 8(39), 65548\u201365565. https:\/\/doi.org\/10.18632\/oncotarget.19214","DOI":"10.18632\/oncotarget.19214"},{"key":"11217_CR115","doi-asserted-by":"publisher","unstructured":"Romero, O. A., Vilarrubi, A., Alburquerque-Bejar, J. J., Gomez, A., Andrades, A., Trastulli, D., \u2026 Sanchez-Cespedes, M. (2021). SMARCA4 deficient tumours are vulnerable to KDM6A\/UTX and KDM6B\/JMJD3 blockade. Nature Communications, 12(1), 4319. https:\/\/doi.org\/10.1038\/s41467-021-24618-3","DOI":"10.1038\/s41467-021-24618-3"},{"issue":"4","key":"11217_CR116","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663\u2013676. https:\/\/doi.org\/10.1016\/j.cell.2006.07.024","journal-title":"Cell"},{"key":"11217_CR117","doi-asserted-by":"publisher","unstructured":"Friedmann-Morvinski, D., Bushong, E. A., Ke, E., Soda, Y., Marumoto, T., Singer, O., \u2026 Verma, I. M. (2012). Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice. Science, 338(6110), 1080\u20131084. https:\/\/doi.org\/10.1126\/science.1226929","DOI":"10.1126\/science.1226929"},{"key":"11217_CR118","doi-asserted-by":"publisher","unstructured":"Ahmadi, Y., Mohammed, T., Abolhasani, S., Abdullah Hamad, S., & Faiq, T. (2025). Dysregulation of the Cyclin D\/E2F activity as a core mechanism driving cancer stem cell plasticity and cell cycle dynamics. Cell Cycle, 1\u201329. https:\/\/doi.org\/10.1080\/15384101.2025.2599081","DOI":"10.1080\/15384101.2025.2599081"},{"key":"11217_CR119","doi-asserted-by":"publisher","unstructured":"Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. Ng., Ayyanan, A., Zhou, A. Y., \u2026 Weinberg, R. A. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 133(4), 704\u2013715. https:\/\/doi.org\/10.1016\/j.cell.2008.03.027","DOI":"10.1016\/j.cell.2008.03.027"},{"key":"11217_CR120","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.660210","volume":"9","author":"ME Heft Neal","year":"2022","unstructured":"Heft Neal, M. E., Brenner, J. C., Prince, M. E. P., & Chinn, S. B. (2022). Advancement in cancer stem cell biology and precision medicine\u2014review article head and neck cancer stem cell plasticity and the tumor microenvironment. Frontiers in Cell and Developmental Biology, 9, Article 660210.","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"11217_CR121","doi-asserted-by":"crossref","unstructured":"Chaffer, C. L., Brueckmann, I., Scheel, C., Kaestli, A. J., Wiggins, P. A., Rodrigues, L. O., \u2026 Polyak, K. (2011). Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proceedings of the National Academy of Sciences, 108(19), 7950\u20137955.","DOI":"10.1073\/pnas.1102454108"},{"key":"11217_CR122","doi-asserted-by":"publisher","unstructured":"Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C. J., Jamieson, C. H. M., Jones, D. L., \u2026 Wahl, G. M. (2006). Cancer stem cells\u2014perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Research, 66(19), 9339\u20139344. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-3126","DOI":"10.1158\/0008-5472.CAN-06-3126"},{"key":"11217_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5402\/2012\/392647","volume":"2012","author":"MH Cruz","year":"2012","unstructured":"Cruz, M. H., Sid\u00e9n, \u00c5., Calaf, G. M., Delwar, Z. M., & Yakisich, J. S. (2012). The Stemness Phenotype Model. ISRN. Oncology, 2012, 1\u201310. https:\/\/doi.org\/10.5402\/2012\/392647","journal-title":"Oncology"},{"issue":"7","key":"11217_CR124","doi-asserted-by":"publisher","first-page":"934","DOI":"10.4252\/wjsc.v13.i7.934","volume":"13","author":"V Kaushik","year":"2021","unstructured":"Kaushik, V., Kulkarni, Y., Felix, K., Azad, N., Krishnan, A., Iyer, V., & Yakisich, J. S. (2021). World Journal of Stem Cells Alternative models of cancer stem cells: The stemness phenotype model, 10 years later. World J Stem Cells, 13(7), 934\u2013943. https:\/\/doi.org\/10.4252\/wjsc.v13.i7.934","journal-title":"World J Stem Cells"},{"key":"11217_CR125","doi-asserted-by":"publisher","unstructured":"Shang, T., Jia, Z., Li, J., Cao, H., Xu, H., Cong, L., \u2026 Liu, J. (2025). Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance. Journal of Hematology & Oncology, 18(1), 32. https:\/\/doi.org\/10.1186\/s13045-025-01684-4","DOI":"10.1186\/s13045-025-01684-4"},{"issue":"7","key":"11217_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/cells14070538","volume":"14","author":"L Haddadin","year":"2025","unstructured":"Haddadin, L., & Sun, X. (2025). Stem cells in cancer: From mechanisms to therapeutic strategies. Cells, 14(7), Article 538. https:\/\/doi.org\/10.3390\/cells14070538","journal-title":"Cells"},{"issue":"3","key":"11217_CR127","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.3390\/cancers7030851","volume":"7","author":"C Cochrane","year":"2015","unstructured":"Cochrane, C., Szczepny, A., Watkins, D., & Cain, J. (2015). Hedgehog signaling in the maintenance of cancer stem cells. Cancers, 7(3), 1554\u20131585. https:\/\/doi.org\/10.3390\/cancers7030851","journal-title":"Cancers"},{"issue":"1","key":"11217_CR128","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13287-022-02856-6","volume":"13","author":"H Rezayatmand","year":"2022","unstructured":"Rezayatmand, H., Razmkhah, M., & Razeghian-Jahromi, I. (2022). Drug resistance in cancer therapy: The Pandora\u2019s box of cancer stem cells. Stem Cell Research & Therapy, 13(1), 181. https:\/\/doi.org\/10.1186\/s13287-022-02856-6","journal-title":"Stem Cell Research & Therapy"},{"key":"11217_CR129","doi-asserted-by":"publisher","unstructured":"Takebe, N., Miele, L., Harris, P. J., Jeong, W., Bando, H., Kahn, M., \u2026 Ivy, S. P. (2015). Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nature Reviews Clinical Oncology, 12(8), 445\u2013464. https:\/\/doi.org\/10.1038\/nrclinonc.2015.61","DOI":"10.1038\/nrclinonc.2015.61"},{"issue":"1","key":"11217_CR130","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/1476-4598-9-212","volume":"9","author":"SS Kanwar","year":"2010","unstructured":"Kanwar, S. S., Yu, Y., Nautiyal, J., Patel, B. B., & Majumdar, A. P. (2010). The Wnt\/\u03b2-catenin pathway regulates growth and maintenance of colonospheres. Molecular Cancer, 9(1), 212. https:\/\/doi.org\/10.1186\/1476-4598-9-212","journal-title":"Molecular Cancer"},{"key":"11217_CR131","doi-asserted-by":"publisher","unstructured":"Song, P., Gao, Z., Bao, Y., Chen, L., Huang, Y., Liu, Y., \u2026 Wei, X. (2024). Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy. Journal of Hematology & Oncology, 17(1), 46. https:\/\/doi.org\/10.1186\/s13045-024-01563-4","DOI":"10.1186\/s13045-024-01563-4"},{"key":"11217_CR132","doi-asserted-by":"publisher","unstructured":"Hu, Y.-Y., Zheng, M.-H., Cheng, G., Li, L., Liang, L., Gao, F., \u2026 Han, H. (2011). Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells. BMC Cancer, 11(1), 82. https:\/\/doi.org\/10.1186\/1471-2407-11-82","DOI":"10.1186\/1471-2407-11-82"},{"issue":"1","key":"11217_CR133","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13045-023-01439-z","volume":"16","author":"X Li","year":"2023","unstructured":"Li, X., Yan, X., Wang, Y., Kaur, B., Han, H., & Yu, J. (2023). The Notch signaling pathway: A potential target for cancer immunotherapy. Journal of Hematology & Oncology, 16(1), 45. https:\/\/doi.org\/10.1186\/s13045-023-01439-z","journal-title":"Journal of Hematology & Oncology"},{"key":"11217_CR134","doi-asserted-by":"publisher","unstructured":"Wang, S.-S., Lv, H.-L., Nie, R.-Z., Liu, Y.-P., Hou, Y.-J., Chen, C., \u2026 Li, P.-F. (2025). Notch signaling in cancer: metabolic reprogramming and therapeutic implications. Frontiers in Immunology, 16. https:\/\/doi.org\/10.3389\/fimmu.2025.1656370","DOI":"10.3389\/fimmu.2025.1656370"},{"issue":"6","key":"11217_CR135","doi-asserted-by":"publisher","first-page":"101042831769226","DOI":"10.1177\/1010428317692266","volume":"39","author":"D-H Lee","year":"2017","unstructured":"Lee, D.-H., Lee, S., & Oh, S. C. (2017). Hedgehog signaling pathway as a potential target in the treatment of advanced gastric cancer. Tumor Biology, 39(6), 101042831769226. https:\/\/doi.org\/10.1177\/1010428317692266","journal-title":"Tumor Biology"},{"issue":"1","key":"11217_CR136","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12943-016-0534-2","volume":"15","author":"Y Miyazaki","year":"2016","unstructured":"Miyazaki, Y., Matsubara, S., Ding, Q., Tsukasa, K., Yoshimitsu, M., Kosai, K., & Takao, S. (2016). Efficient elimination of pancreatic cancer stem cells by hedgehog\/GLI inhibitor GANT61 in combination with mTOR inhibition. Molecular Cancer, 15(1), 49. https:\/\/doi.org\/10.1186\/s12943-016-0534-2","journal-title":"Molecular Cancer"},{"issue":"7","key":"11217_CR137","doi-asserted-by":"publisher","first-page":"873","DOI":"10.2174\/156652409789105570","volume":"9","author":"Y Katoh","year":"2009","unstructured":"Katoh, Y., & Katoh, M. (2009). Hedgehog target genes: Mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. Current Molecular Medicine, 9(7), 873\u2013886. https:\/\/doi.org\/10.2174\/156652409789105570","journal-title":"Current Molecular Medicine"},{"issue":"1","key":"11217_CR138","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1476-4598-8-40","volume":"8","author":"B Ju","year":"2009","unstructured":"Ju, B., Spitsbergen, J., Eden, C. J., Taylor, M. R., & Chen, W. (2009). Co-activation of hedgehog and AKT pathways promote tumorigenesis in zebrafish. Molecular Cancer, 8(1), 40. https:\/\/doi.org\/10.1186\/1476-4598-8-40","journal-title":"Molecular Cancer"},{"key":"11217_CR139","doi-asserted-by":"publisher","unstructured":"Karami fath, M., Ebrahimi, M., Nourbakhsh, E., Zia Hazara, A., Mirzaei, A., Shafieyari, S., \u2026 Barati, G. (2022). PI3K\/Akt\/mTOR signaling pathway in cancer stem cells. Pathology - Research and Practice, 237, 154010. https:\/\/doi.org\/10.1016\/j.prp.2022.154010","DOI":"10.1016\/j.prp.2022.154010"},{"issue":"1","key":"11217_CR140","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13287-025-04218-4","volume":"16","author":"C Zhang","year":"2025","unstructured":"Zhang, C., Xu, S., Yin, C., Hu, S., & Liu, P. (2025). The role of the mTOR pathway in breast cancer stem cells (BCSCs): Mechanisms and therapeutic potentials. Stem Cell Research & Therapy, 16(1), 156. https:\/\/doi.org\/10.1186\/s13287-025-04218-4","journal-title":"Stem Cell Research & Therapy"},{"issue":"1","key":"11217_CR141","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1186\/s12885-019-5824-9","volume":"19","author":"J Deng","year":"2019","unstructured":"Deng, J., Bai, X., Feng, X., Ni, J., Beretov, J., Graham, P., & Li, Y. (2019). Inhibition of PI3K\/Akt\/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression. BMC Cancer, 19(1), 618. https:\/\/doi.org\/10.1186\/s12885-019-5824-9","journal-title":"BMC Cancer"},{"key":"11217_CR142","doi-asserted-by":"publisher","unstructured":"Chen, S., Fisher, R. C., Signs, S., Molina, L. A., Shenoy, A. K., Lopez, M.-C., \u2026 Huang, E. H. (2017). Inhibition of PI3K\/Akt\/mTOR signaling in PI3KR2-overexpressing colon cancer stem cells reduces tumor growth due to apoptosis. Oncotarget, 8(31), 50476\u201350488. https:\/\/doi.org\/10.18632\/oncotarget.9919","DOI":"10.18632\/oncotarget.9919"},{"key":"11217_CR143","doi-asserted-by":"publisher","unstructured":"Eckerdt, F. D., Bell, J. B., Gonzalez, C., Oh, M. S., Perez, R. E., Mazewski, C., \u2026 Platanias, L. C. (2020). Combined PI3K\u03b1-mTOR Targeting of Glioma Stem Cells. Scientific Reports, 10(1), 21873. https:\/\/doi.org\/10.1038\/s41598-020-78788-z","DOI":"10.1038\/s41598-020-78788-z"},{"key":"11217_CR144","doi-asserted-by":"publisher","unstructured":"Zhang, H.-F., Wu, C., Alshareef, A., Gupta, N., Zhao, Q., Xu, X.-E., \u2026 Lai, R. (2016). The PI3K\/AKT\/c-MYC Axis Promotes the Acquisition of Cancer Stem-Like Features in Esophageal Squamous Cell Carcinoma. Stem Cells, 34(8), 2040\u20132051. https:\/\/doi.org\/10.1002\/stem.2395","DOI":"10.1002\/stem.2395"},{"key":"11217_CR145","doi-asserted-by":"publisher","unstructured":"Rokavec, M., \u00d6ner, M. G., Li, H., Jackstadt, R., Jiang, L., Lodygin, D., \u2026 Hermeking, H. (2014). IL-6R\/STAT3\/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. Journal of Clinical Investigation, 124(4), 1853\u20131867. https:\/\/doi.org\/10.1172\/JCI73531","DOI":"10.1172\/JCI73531"},{"key":"11217_CR146","doi-asserted-by":"publisher","unstructured":"Zhang, X., Hu, F., Li, G., Li, G., Yang, X., Liu, L., \u2026 Feng, Y. (2018). Human colorectal cancer-derived mesenchymal stem cells promote colorectal cancer progression through IL-6\/JAK2\/STAT3 signaling. Cell Death & Disease, 9(2), 25. https:\/\/doi.org\/10.1038\/s41419-017-0176-3","DOI":"10.1038\/s41419-017-0176-3"},{"key":"11217_CR147","doi-asserted-by":"publisher","unstructured":"Kim, B., Seo, Y., Kwon, J., Shin, Y., Kim, S., Park, S. J., \u2026 Il Kim, T. (2021). IL\u20106 and IL\u20108, secreted by myofibroblasts in the tumor microenvironment, activate HES1 to expand the cancer stem cell population in early colorectal tumor. Molecular Carcinogenesis, 60(3), 188\u2013200. https:\/\/doi.org\/10.1002\/mc.23283","DOI":"10.1002\/mc.23283"},{"key":"11217_CR148","doi-asserted-by":"publisher","unstructured":"Hsu, J.-M., Xia, W., Hsu, Y.-H., Chan, L.-C., Yu, W.-H., Cha, J.-H., \u2026 Hung, M.-C. (2018). STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion. Nature Communications, 9(1), 1908. https:\/\/doi.org\/10.1038\/s41467-018-04313-6","DOI":"10.1038\/s41467-018-04313-6"},{"issue":"4","key":"11217_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2019.03.005","volume":"1866","author":"IS Mohiuddin","year":"2020","unstructured":"Mohiuddin, I. S., Wei, S.-J., & Kang, M. H. (2020). Role of OCT4 in cancer stem-like cells and chemotherapy resistance. Biochimica et Biophysica Acta - Molecular Basis of Disease, 1866(4), Article 165432. https:\/\/doi.org\/10.1016\/j.bbadis.2019.03.005","journal-title":"Biochimica et Biophysica Acta - Molecular Basis of Disease"},{"key":"11217_CR150","doi-asserted-by":"publisher","unstructured":"Leis, O., Eguiara, A., Lopez-Arribillaga, E., Alberdi, M. J., Hernandez-Garcia, S., Elorriaga, K., \u2026 Martin, A. G. (2012). Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene, 31(11), 1354\u20131365. https:\/\/doi.org\/10.1038\/onc.2011.338","DOI":"10.1038\/onc.2011.338"},{"key":"11217_CR151","doi-asserted-by":"publisher","unstructured":"Lin, X., Li, J., Yin, G., Zhao, Q., Elias, D., Lykkesfeldt, A. E., \u2026 Ditzel, H. J. (2013). Integrative analyses of gene expression and DNA methylation profiles in breast cancer cell line models of tamoxifen-resistance indicate a potential role of cells with stem-like properties. Breast Cancer Research, 15(6), R119. https:\/\/doi.org\/10.1186\/bcr3588","DOI":"10.1186\/bcr3588"},{"key":"11217_CR152","doi-asserted-by":"publisher","unstructured":"Jeter, C. R., Liu, B., Liu, X., Chen, X., Liu, C., Calhoun-Davis, T., \u2026 Tang, D. G. (2011). NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene, 30(36), 3833\u20133845. https:\/\/doi.org\/10.1038\/onc.2011.114","DOI":"10.1038\/onc.2011.114"},{"key":"11217_CR153","doi-asserted-by":"publisher","unstructured":"Wang, J., Wang, H., Li, Z., Wu, Q., Lathia, J. D., McLendon, R. E., \u2026 Rich, J. N. (2008). c-Myc Is required for maintenance of glioma cancer stem cells. PLoS ONE, 3(11), e3769. https:\/\/doi.org\/10.1371\/journal.pone.0003769","DOI":"10.1371\/journal.pone.0003769"},{"key":"11217_CR154","doi-asserted-by":"publisher","unstructured":"Gangemi, R. M. R., Griffero, F., Marubbi, D., Perera, M., Capra, M. C., Malatesta, P., \u2026 Corte, G. (2009). SOX2 Silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells, 27(1), 40\u201348. https:\/\/doi.org\/10.1634\/stemcells.2008-0493","DOI":"10.1634\/stemcells.2008-0493"},{"key":"11217_CR155","doi-asserted-by":"publisher","unstructured":"Wang, D., Lu, P., Zhang, H., Luo, M., Zhang, X., Wei, X., \u2026 Liu, C. (2014). Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients. Oncotarget, 5(21), 10803\u201310815. https:\/\/doi.org\/10.18632\/oncotarget.2506","DOI":"10.18632\/oncotarget.2506"},{"key":"11217_CR156","doi-asserted-by":"publisher","unstructured":"Zhang, J., Espinoza, L. A., Kinders, R. J., Lawrence, S. M., Pfister, T. D., Zhou, M., \u2026 Jessup, J. M. (2013). NANOG modulates stemness in human colorectal cancer. Oncogene, 32(37), 4397\u20134405. https:\/\/doi.org\/10.1038\/onc.2012.461","DOI":"10.1038\/onc.2012.461"},{"key":"11217_CR157","doi-asserted-by":"publisher","unstructured":"Das, B., Pal, B., Bhuyan, R., Li, H., Sarma, A., Gayan, S., \u2026 Felsher, D. W. (2019). MYC regulates the HIF2\u03b1 stemness pathway via Nanog and Sox2 to maintain self-renewal in cancer stem cells versus non-stem cancer cells. Cancer Research, 79(16), 4015\u20134025. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-2847","DOI":"10.1158\/0008-5472.CAN-18-2847"},{"key":"11217_CR158","doi-asserted-by":"publisher","unstructured":"Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., \u2026 Rich, J. N. (2009). Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell, 15(6), 501\u2013513. https:\/\/doi.org\/10.1016\/j.ccr.2009.03.018","DOI":"10.1016\/j.ccr.2009.03.018"},{"issue":"10","key":"11217_CR159","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108309","volume":"9","author":"R Petruzzelli","year":"2014","unstructured":"Petruzzelli, R., Christensen, D. R., Parry, K. L., Sanchez-Elsner, T., & Houghton, F. D. (2014). HIF-2\u03b1 regulates NANOG expression in human embryonic stem cells following hypoxia and reoxygenation through the interaction with an Oct-Sox cis regulatory element. PLoS ONE, 9(10), Article e108309. https:\/\/doi.org\/10.1371\/journal.pone.0108309","journal-title":"PLoS ONE"},{"issue":"4","key":"11217_CR160","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/mco2.104","volume":"2","author":"T Zhang","year":"2021","unstructured":"Zhang, T., Ma, C., Zhang, Z., Zhang, H., & Hu, H. (2021). NF-\u03baB signaling in inflammation and cancer. MedComm, 2(4), 618\u2013653. https:\/\/doi.org\/10.1002\/mco2.104","journal-title":"MedComm"},{"key":"11217_CR161","doi-asserted-by":"publisher","unstructured":"Haselager, M., Thijssen, R., West, C., Young, L., Van Kampen, R., Willmore, E., \u2026 Eldering, E. (2021). Regulation of Bcl-XL by non-canonical NF-\u03baB in the context of CD40-induced drug resistance in CLL. Cell Death & Differentiation, 28(5), 1658\u20131668. https:\/\/doi.org\/10.1038\/s41418-020-00692-w","DOI":"10.1038\/s41418-020-00692-w"},{"key":"11217_CR162","doi-asserted-by":"publisher","unstructured":"Li, C.-W., Xia, W., Huo, L., Lim, S.-O., Wu, Y., Hsu, J. L., \u2026 Hung, M.-C. (2012). Epithelial\u2013mesenchymal transition induced by TNF-\u03b1 Requires NF-\u03baB\u2013Mediated transcriptional upregulation of twist1. Cancer Research, 72(5), 1290\u20131300. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3123","DOI":"10.1158\/0008-5472.CAN-11-3123"},{"key":"11217_CR163","doi-asserted-by":"publisher","unstructured":"Pires, B. R. B., Mencalha, A. L., Ferreira, G. M., de Souza, W. F., Morgado-D\u00edaz, J. A., Maia, A. M., \u2026 Abdelhay, E. S. F. W. (2017). NF-kappaB is involved in the regulation of EMT genes in breast cancer cells. PLOS ONE, 12(1), e0169622. https:\/\/doi.org\/10.1371\/journal.pone.0169622","DOI":"10.1371\/journal.pone.0169622"},{"key":"11217_CR164","doi-asserted-by":"publisher","unstructured":"Che, Q., Liu, B.-Y., Wang, F.-Y., He, Y.-Y., Lu, W., Liao, Y., \u2026 Wan, X.-P. (2014). Interleukin 6 promotes endometrial cancer growth through an autocrine feedback loop involving ERK\u2013NF-\u03baB signaling pathway. Biochemical and Biophysical Research Communications, 446(1), 167\u2013172. https:\/\/doi.org\/10.1016\/j.bbrc.2014.02.080","DOI":"10.1016\/j.bbrc.2014.02.080"},{"key":"11217_CR165","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqaa152","author":"E Smart","year":"2020","unstructured":"Smart, E., Semina, S. E., & Frasor, J. (2020). Update on the role of NF\u03baB in promoting aggressive phenotypes of estrogen receptor\u2013positive breast cancer. Endocrinology. https:\/\/doi.org\/10.1210\/endocr\/bqaa152","journal-title":"Endocrinology"},{"key":"11217_CR166","doi-asserted-by":"publisher","unstructured":"Manore, S. G., Doheny, D. L., Wong, G. L., & Lo, H.-W. (2022). IL-6\/JAK\/STAT3 Signaling in breast cancer metastasis: biology and treatment. Frontiers in Oncology, 12. https:\/\/doi.org\/10.3389\/fonc.2022.866014","DOI":"10.3389\/fonc.2022.866014"},{"key":"11217_CR167","doi-asserted-by":"publisher","unstructured":"Ma, Y., Zhu, Y., Shang, L., Qiu, Y., Shen, N., Wang, J., \u2026 Luo, M. (2023). LncRNA XIST regulates breast cancer stem cells by activating proinflammatory IL-6\/STAT3 signaling. Oncogene, 42(18), 1419\u20131437. https:\/\/doi.org\/10.1038\/s41388-023-02652-3","DOI":"10.1038\/s41388-023-02652-3"},{"issue":"2","key":"11217_CR168","doi-asserted-by":"publisher","first-page":"557","DOI":"10.21037\/tcr.2019.03.16","volume":"8","author":"H Wei","year":"2019","unstructured":"Wei, H. (2019). Interleukin 6 signaling maintains the stem-like properties of bladder cancer stem cells. Translational Cancer Research, 8(2), 557\u2013566. https:\/\/doi.org\/10.21037\/tcr.2019.03.16","journal-title":"Translational Cancer Research"},{"issue":"1","key":"11217_CR169","doi-asserted-by":"publisher","first-page":"10194","DOI":"10.1038\/srep10194","volume":"5","author":"R Thakur","year":"2015","unstructured":"Thakur, R., Trivedi, R., Rastogi, N., Singh, M., & Mishra, D. P. (2015). Inhibition of STAT3, FAK and Src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancer. Scientific Reports, 5(1), 10194. https:\/\/doi.org\/10.1038\/srep10194","journal-title":"Scientific Reports"},{"key":"11217_CR170","doi-asserted-by":"publisher","unstructured":"Dave, B., Landis, M. D., Dobrolecki, L. E., Wu, M.-F., Zhang, X., Westbrook, T. F., \u2026 Chang, J. C. (2012). Selective small molecule stat3 inhibitor reduces breast cancer tumor-initiating cells and improves recurrence free survival in a human-xenograft model. PLoS ONE, 7(8), e30207. https:\/\/doi.org\/10.1371\/journal.pone.0030207","DOI":"10.1371\/journal.pone.0030207"},{"issue":"42","key":"11217_CR171","doi-asserted-by":"publisher","first-page":"16975","DOI":"10.1073\/pnas.1315862110","volume":"110","author":"Y Wang","year":"2013","unstructured":"Wang, Y., van Boxel-Dezaire, A. H. H., Cheon, H., Yang, J., & Stark, G. R. (2013). STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor. Proceedings of the National Academy of Sciences, 110(42), 16975\u201316980. https:\/\/doi.org\/10.1073\/pnas.1315862110","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"17","key":"11217_CR172","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1038\/sj.onc.1203548","volume":"19","author":"Y-Z Wang","year":"2000","unstructured":"Wang, Y.-Z., Wharton, W., Garcia, R., Kraker, A., Jove, R., & Pledger, W. J. (2000). Activation of Stat3 preassembled with platelet-derived growth factor \u03b2 receptors requires Src kinase activity. Oncogene, 19(17), 2075\u20132085. https:\/\/doi.org\/10.1038\/sj.onc.1203548","journal-title":"Oncogene"},{"issue":"7","key":"11217_CR173","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1172\/JCI3785","volume":"102","author":"JR Grandis","year":"1998","unstructured":"Grandis, J. R., Drenning, S. D., Chakraborty, A., Zhou, M. Y., Zeng, Q., Pitt, A. S., & Tweardy, D. J. (1998). Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro. Journal of Clinical Investigation, 102(7), 1385\u20131392. https:\/\/doi.org\/10.1172\/JCI3785","journal-title":"Journal of Clinical Investigation"},{"key":"11217_CR174","doi-asserted-by":"publisher","unstructured":"Wang, Z.-Y., Zhang, J.-A., Wu, X.-J., Liang, Y.-F., Lu, Y.-B., Gao, Y.-C., \u2026 Zhong, J. (2016). IL-6 inhibition reduces STAT3 activation and enhances the antitumor effect of carboplatin. Mediators of Inflammation, 2016, 1\u20138. https:\/\/doi.org\/10.1155\/2016\/8026494","DOI":"10.1155\/2016\/8026494"},{"issue":"1","key":"11217_CR175","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41420-023-01638-0","volume":"9","author":"TTT Phan","year":"2023","unstructured":"Phan, T. T. T., Truong, N. V., Wu, W.-G., Su, Y.-C., Hsu, T.-S., & Lin, L.-Y. (2023). Tumor suppressor p53 mediates interleukin-6 expression to enable cancer cell evasion of genotoxic stress. Cell Death Discovery, 9(1), 340. https:\/\/doi.org\/10.1038\/s41420-023-01638-0","journal-title":"Cell Death Discovery"},{"key":"11217_CR176","doi-asserted-by":"publisher","unstructured":"Cao, Z., Shu, Y., Wang, J., Wang, C., Feng, T., Yang, L., \u2026 Zou, L. (2022). Super enhancers: Pathogenic roles and potential therapeutic targets for acute myeloid leukemia (AML). Genes & Diseases, 9(6), 1466\u20131477. https:\/\/doi.org\/10.1016\/j.gendis.2022.01.006","DOI":"10.1016\/j.gendis.2022.01.006"},{"key":"11217_CR177","doi-asserted-by":"publisher","unstructured":"Choi, Ah., Illendula, A., Pulikkan, J. A., Roderick, J. E., Tesell, J., Yu, J., \u2026 Kelliher, M. A. (2017). RUNX1 is required for oncogenic Myb and Myc enhancer activity in T-cell acute lymphoblastic leukemia. Blood, 130(15), 1722\u20131733. https:\/\/doi.org\/10.1182\/blood-2017-03-775536","DOI":"10.1182\/blood-2017-03-775536"},{"key":"11217_CR178","doi-asserted-by":"publisher","unstructured":"Zhou, J., Wang, S., Nie, D., Lai, P., Li, Y., Li, Y., \u2026 Pan, J. (2021). Super-enhancer landscape reveals leukemia stem cell reliance on X-box binding protein 1 as a therapeutic vulnerability. Science Translational Medicine, 13(612). https:\/\/doi.org\/10.1126\/scitranslmed.abh3462","DOI":"10.1126\/scitranslmed.abh3462"},{"issue":"12","key":"11217_CR179","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1002\/stem.2909","volume":"36","author":"D Ganguly","year":"2018","unstructured":"Ganguly, D., Sims, M., Cai, C., Fan, M., & Pfeffer, L. M. (2018). Chromatin remodeling factor BRG1 regulates stemness and chemosensitivity of glioma initiating cells. Stem Cells, 36(12), 1804\u20131815. https:\/\/doi.org\/10.1002\/stem.2909","journal-title":"Stem Cells"},{"issue":"6","key":"11217_CR180","doi-asserted-by":"publisher","first-page":"919","DOI":"10.2217\/epi-2017-0034","volume":"9","author":"Q Wu","year":"2017","unstructured":"Wu, Q., Lian, J. B., Stein, J. L., Stein, G. S., Nickerson, J. A., & Imbalzano, A. N. (2017). The BRG1 ATPase of human SWI\/SNF chromatin remodeling enzymes as a driver of cancer. Epigenomics, 9(6), 919\u2013931. https:\/\/doi.org\/10.2217\/epi-2017-0034","journal-title":"Epigenomics"},{"issue":"31","key":"11217_CR181","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1038\/s41388-023-02773-9","volume":"42","author":"SM Navickas","year":"2023","unstructured":"Navickas, S. M., Giles, K. A., Brettingham-Moore, K. H., & Taberlay, P. C. (2023). The role of chromatin remodeler SMARCA4\/BRG1 in brain cancers: A potential therapeutic target. Oncogene, 42(31), 2363\u20132373. https:\/\/doi.org\/10.1038\/s41388-023-02773-9","journal-title":"Oncogene"},{"key":"11217_CR182","doi-asserted-by":"publisher","unstructured":"Kadoch, C., & Crabtree, G. R. (2015). Mammalian SWI\/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics. Science Advances, 1(5). https:\/\/doi.org\/10.1126\/sciadv.1500447","DOI":"10.1126\/sciadv.1500447"},{"key":"11217_CR183","doi-asserted-by":"publisher","unstructured":"Azzoni, V., Wicinski, J., Macario, M., Castagn\u00e9, M., Finetti, P., Ambrosova, K., \u2026 Ginestier, C. (2022). BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cells. Cell Death & Disease, 13(2), 96. https:\/\/doi.org\/10.1038\/s41419-022-04538-w","DOI":"10.1038\/s41419-022-04538-w"},{"key":"11217_CR184","doi-asserted-by":"publisher","unstructured":"Herzog, A. E., Somayaji, R., & N\u00f6r, J. E. (2023). Bmi-1: A master regulator of head and neck cancer stemness. Frontiers in Oral Health, 4. https:\/\/doi.org\/10.3389\/froh.2023.1080255","DOI":"10.3389\/froh.2023.1080255"},{"issue":"1","key":"11217_CR185","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41392-025-02340-6","volume":"10","author":"C Galassi","year":"2025","unstructured":"Galassi, C., Manic, G., Esteller, M., Galluzzi, L., & Vitale, I. (2025). Epigenetic regulation of cancer stemness. Signal Transduction and Targeted Therapy, 10(1), 243. https:\/\/doi.org\/10.1038\/s41392-025-02340-6","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"11217_CR186","doi-asserted-by":"publisher","unstructured":"Thurlings, I., & de Bruin, A. (2016). E2F transcription factors control the roller coaster ride of cell cycle gene expression (pp. 71\u201388). https:\/\/doi.org\/10.1007\/978-1-4939-2957-3_4","DOI":"10.1007\/978-1-4939-2957-3_4"},{"issue":"16","key":"11217_CR187","doi-asserted-by":"publisher","first-page":"5797","DOI":"10.1128\/MCB.20.16.5797-5807.2000","volume":"20","author":"J Wells","year":"2000","unstructured":"Wells, J., Boyd, K. E., Fry, C. J., Bartley, S. M., & Farnham, P. J. (2000). Target gene specificity of E2F and pocket protein family members in living cells. Molecular and Cellular Biology, 20(16), 5797\u20135807.","journal-title":"Molecular and Cellular Biology"},{"issue":"10","key":"11217_CR188","first-page":"6501","volume":"13","author":"K Helin","year":"1993","unstructured":"Helin, K., Harlow, E. D., & Fattaey, A. (1993). Inhibition of E2F\u20131 transactivation by direct binding of the retinoblastoma protein. Molecular and Cellular Biology, 13(10), 6501\u20136508.","journal-title":"Molecular and Cellular Biology"},{"issue":"35","key":"11217_CR189","doi-asserted-by":"publisher","first-page":"32627","DOI":"10.1074\/jbc.M102067200","volume":"276","author":"SE Lang","year":"2001","unstructured":"Lang, S. E., McMahon, S. B., Cole, M. D., & Hearing, P. (2001). E2F transcriptional activation requires TRRAP and GCN5 Cofactors. Journal of Biological Chemistry, 276(35), 32627\u201332634. https:\/\/doi.org\/10.1074\/jbc.M102067200","journal-title":"Journal of Biological Chemistry"},{"key":"11217_CR190","doi-asserted-by":"publisher","unstructured":"Chong, J.-L., Wenzel, P. L., S\u00e1enz-Robles, M. T., Nair, V., Ferrey, A., Hagan, J. P., \u2026 Leone, G. (2009). E2f1\u20133 switch from activators in progenitor cells to repressors in differentiating cells. Nature, 462(7275), 930\u2013934. https:\/\/doi.org\/10.1038\/nature08677","DOI":"10.1038\/nature08677"},{"issue":"4","key":"11217_CR191","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2174\/1566524022666220308095834","volume":"23","author":"ZA Shah","year":"2023","unstructured":"Shah, Z. A., Nouroz, F., Ejaz, S., & Tayyeb, A. (2023). An insight into the role of E2F1 in breast cancer progression, drug resistance, and metastasis. Current Molecular Medicine, 23(4), 365\u2013376. https:\/\/doi.org\/10.2174\/1566524022666220308095834","journal-title":"Current Molecular Medicine"},{"key":"11217_CR192","doi-asserted-by":"publisher","unstructured":"Liu, Q., Guo, Z., Li, G., Zhang, Y., Liu, X., Li, B., \u2026 Li, X. (2023). Cancer stem cells and their niche in cancer progression and therapy. Cancer Cell International, 23(1), 305. https:\/\/doi.org\/10.1186\/s12935-023-03130-2","DOI":"10.1186\/s12935-023-03130-2"},{"issue":"11","key":"11217_CR193","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3390\/cells15110997","volume":"15","author":"D Pigo\u0144-Zaj\u0105c","year":"2026","unstructured":"Pigo\u0144-Zaj\u0105c, D., Bryczek, M., Leszczuk, A., & Zaj\u0105c, A. (2026). The niche awakens: Comprehension of cancer stem cells\u2019 microenvironment to plan new therapeutic strategies. Cells, 15(11), 997.","journal-title":"Cells"},{"issue":"8","key":"11217_CR194","doi-asserted-by":"publisher","DOI":"10.3390\/cells8080926","volume":"8","author":"L Barbato","year":"2019","unstructured":"Barbato, L., Bocchetti, M., Di Biase, A., & Regad, T. (2019). Cancer stem cells and targeting strategies. Cells, 8(8), Article 926.","journal-title":"Cells"},{"key":"11217_CR195","doi-asserted-by":"publisher","unstructured":"Abd, G. M., Laird, M. C., Ku, J. C., & Li, Y. (2023). Hypoxia-induced cancer cell reprogramming: a review on how cancer stem cells arise. Frontiers in Oncology, 13. https:\/\/doi.org\/10.3389\/fonc.2023.1227884","DOI":"10.3389\/fonc.2023.1227884"},{"key":"11217_CR196","doi-asserted-by":"publisher","unstructured":"Wang, P., Gong, S., Liao, B., Pan, J., Wang, J., Zou, D., \u2026 Wu, N. (2022). HIF1\u03b1\/HIF2\u03b1 induces glioma cell dedifferentiation into cancer stem cells through Sox2 under hypoxic conditions. Journal of Cancer, 13(1), 1\u201314. https:\/\/doi.org\/10.7150\/jca.54402","DOI":"10.7150\/jca.54402"},{"key":"11217_CR197","doi-asserted-by":"publisher","unstructured":"Chen, W.-J., Ho, C.-C., Chang, Y.-L., Chen, H.-Y., Lin, C.-A., Ling, T.-Y., \u2026 Yang, P.-C. (2014). Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling. Nature Communications, 5(1), 3472. https:\/\/doi.org\/10.1038\/ncomms4472","DOI":"10.1038\/ncomms4472"},{"key":"11217_CR198","doi-asserted-by":"publisher","unstructured":"Liu, X., Ye, Y., Zhu, L., Xiao, X., Zhou, B., Gu, Y., \u2026 Zhao, Q. (2023). Niche stiffness sustains cancer stemness via TAZ and NANOG phase separation. Nature Communications, 14(1), 238. https:\/\/doi.org\/10.1038\/s41467-023-35856-y","DOI":"10.1038\/s41467-023-35856-y"},{"key":"11217_CR199","doi-asserted-by":"publisher","unstructured":"Ma, Y., Lv, H., Xing, F., Xiang, W., Wu, Z., Feng, Q., \u2026 Yang, W. (2024). Cancer stem cell-immune cell crosstalk in the tumor microenvironment for liver cancer progression. Frontiers of Medicine, 18(3), 430\u2013445. https:\/\/doi.org\/10.1007\/s11684-023-1049-z","DOI":"10.1007\/s11684-023-1049-z"},{"key":"11217_CR200","doi-asserted-by":"publisher","unstructured":"Verona, F., Di Bella, S., Schirano, R., Manfredi, C., Angeloro, F., Bozzari, G., \u2026 Veschi, V. (2025). Cancer stem cells and tumor-associated macrophages as mates in tumor progression: mechanisms of crosstalk and advanced bioinformatic tools to dissect their phenotypes and interaction. Frontiers in Immunology, 16. https:\/\/doi.org\/10.3389\/fimmu.2025.1529847","DOI":"10.3389\/fimmu.2025.1529847"},{"key":"11217_CR201","doi-asserted-by":"publisher","unstructured":"Yu, M., Yu, H., Wang, H., Xu, X., Sun, Z., Chen, W., \u2026 Zhang, X. (2024). Tumor-associated macrophages activated in the tumor environment of hepatocellular carcinoma: Characterization and treatment (Review). International Journal of Oncology, 65(4), 100. https:\/\/doi.org\/10.3892\/ijo.2024.5688","DOI":"10.3892\/ijo.2024.5688"},{"issue":"3","key":"11217_CR202","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.stem.2015.02.015","volume":"16","author":"V Plaks","year":"2015","unstructured":"Plaks, V., Kong, N., & Werb, Z. (2015). The cancer stem cell niche: How essential is the niche in regulating stemness of tumor cells? Cell Stem Cell, 16(3), 225\u2013238. https:\/\/doi.org\/10.1016\/j.stem.2015.02.015","journal-title":"Cell Stem Cell"},{"issue":"9","key":"11217_CR203","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/s41419-018-0903-4","volume":"9","author":"D Kim","year":"2018","unstructured":"Kim, D., Choi, B., Ryoo, I., & Kwak, M.-K. (2018). High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: Inhibitory role of all-trans retinoic acid in ALDH\/NRF2 signaling. Cell Death & Disease, 9(9), 896. https:\/\/doi.org\/10.1038\/s41419-018-0903-4","journal-title":"Cell Death & Disease"},{"key":"11217_CR204","doi-asserted-by":"publisher","unstructured":"Liu, Y., Burness, M. L., Martin-Trevino, R., Guy, J., Bai, S., Harouaka, R., \u2026 Liu, S. (2017). RAD51 mediates resistance of cancer stem cells to PARP inhibition in triple-negative breast cancer. Clinical Cancer Research, 23(2), 514\u2013522. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-1348","DOI":"10.1158\/1078-0432.CCR-15-1348"},{"key":"11217_CR205","doi-asserted-by":"publisher","unstructured":"Yin, W., Xiang, D., Wang, T., Zhang, Y., Pham, C. V., Zhou, S., \u2026 Duan, W. (2021). The inhibition of ABCB1\/MDR1 or ABCG2\/BCRP enables doxorubicin to eliminate liver cancer stem cells. Scientific Reports, 11(1), 10791. https:\/\/doi.org\/10.1038\/s41598-021-89931-9","DOI":"10.1038\/s41598-021-89931-9"},{"key":"11217_CR206","doi-asserted-by":"publisher","unstructured":"Ma, L., Zhang, G., Miao, X., Deng, X., Wu, Y., Liu, Y., \u2026 Xiao, G. (2013). Cancer stem\u2010like cell properties are regulated by <scp>EGFR<\/scp> \/ <scp>AKT<\/scp> \/\u03b2\u2013catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma. The FEBS Journal, 280(9), 2027\u20132041. https:\/\/doi.org\/10.1111\/febs.12226","DOI":"10.1111\/febs.12226"},{"issue":"8","key":"11217_CR207","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002888","volume":"3","author":"A-P Morel","year":"2008","unstructured":"Morel, A.-P., Li\u00e8vre, M., Thomas, C., Hinkal, G., Ansieau, S., & Puisieux, A. (2008). Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE, 3(8), Article e2888. https:\/\/doi.org\/10.1371\/journal.pone.0002888","journal-title":"PLoS ONE"},{"key":"11217_CR208","doi-asserted-by":"publisher","unstructured":"Brown, J. A., Yonekubo, Y., Hanson, N., Sastre-Perona, A., Basin, A., Rytlewski, J. A., \u2026 Schober, M. (2017). TGF-\u03b2-induced quiescence mediates chemoresistance of tumor-propagating cells in squamous cell carcinoma. Cell Stem Cell, 21(5), 650\u2013664.e8. https:\/\/doi.org\/10.1016\/j.stem.2017.10.001","DOI":"10.1016\/j.stem.2017.10.001"},{"key":"11217_CR209","doi-asserted-by":"publisher","unstructured":"Ryoo, I., Lee, S., & Kwak, M.-K. (2016). Redox modulating NRF2: a potential mediator of cancer stem cell resistance. Oxidative Medicine and Cellular Longevity, 2016(1). https:\/\/doi.org\/10.1155\/2016\/2428153","DOI":"10.1155\/2016\/2428153"},{"key":"11217_CR210","doi-asserted-by":"publisher","unstructured":"Chen, Y., Zhao, H., Liang, W., Jiang, E., Zhou, X., Shao, Z., \u2026 Shang, Z. (2022). Autophagy regulates the cancer stem cell phenotype of head and neck squamous cell carcinoma through the noncanonical FOXO3\/SOX2 axis. Oncogene, 41(5), 634\u2013646. https:\/\/doi.org\/10.1038\/s41388-021-02115-7","DOI":"10.1038\/s41388-021-02115-7"},{"key":"11217_CR211","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116781","volume":"234","author":"M Najafi","year":"2019","unstructured":"Najafi, M., Mortezaee, K., & Majidpoor, J. (2019). Cancer stem cell (CSC) resistance drivers. Life Sciences, 234, Article 116781. https:\/\/doi.org\/10.1016\/j.lfs.2019.116781","journal-title":"Life Sciences"},{"key":"11217_CR212","doi-asserted-by":"publisher","unstructured":"Nunes, T., Hamdan, D., Leboeuf, C., El Bouchtaoui, M., Gapihan, G., Nguyen, T. T., \u2026 Janin, A. (2018). Targeting cancer stem cells to overcome chemoresistance. International Journal of Molecular Sciences, 19(12), 4036. https:\/\/doi.org\/10.3390\/ijms19124036","DOI":"10.3390\/ijms19124036"},{"issue":"1","key":"11217_CR213","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1479-5876-9-50","volume":"9","author":"H-G Liu","year":"2011","unstructured":"Liu, H.-G., Chen, C., Yang, H., Pan, Y.-F., & Zhang, X.-H. (2011). Cancer stem cell subsets and their relationships. Journal of Translational Medicine, 9(1), 50. https:\/\/doi.org\/10.1186\/1479-5876-9-50","journal-title":"Journal of Translational Medicine"},{"key":"11217_CR214","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-018-0426-4","volume":"25","author":"AZ Ayob","year":"2018","unstructured":"Ayob, A. Z., & Ramasamy, T. S. (2018). Cancer stem cells as key drivers of tumour progression. Journal of Biomedical Science, 25, 1\u201318.","journal-title":"Journal of Biomedical Science"},{"issue":"3","key":"11217_CR215","doi-asserted-by":"publisher","DOI":"10.4331\/wjbc.v6.i3.57","volume":"6","author":"Q-E Wang","year":"2015","unstructured":"Wang, Q.-E. (2015). DNA damage responses in cancer stem cells: Implications for cancer therapeutic strategies. World Journal of Biological Chemistry, 6(3), Article 57. https:\/\/doi.org\/10.4331\/wjbc.v6.i3.57","journal-title":"World Journal of Biological Chemistry"},{"key":"11217_CR216","doi-asserted-by":"publisher","unstructured":"Meyer, F., Engel, A. M., Krause, A. K., Wagner, T., Poole, L., Dubrovska, A., \u2026 Borgmann, K. (2022). Efficient DNA repair mitigates replication stress resulting in less immunogenic cytosolic DNA in Radioresistant breast cancer stem cells. Frontiers in Immunology, 13. https:\/\/doi.org\/10.3389\/fimmu.2022.765284","DOI":"10.3389\/fimmu.2022.765284"},{"issue":"6","key":"11217_CR217","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15061897","volume":"15","author":"MS Gillespie","year":"2023","unstructured":"Gillespie, M. S., Ward, C. M., & Davies, C. C. (2023). DNA repair and therapeutic strategies in cancer stem cells. Cancers, 15(6), Article 1897. https:\/\/doi.org\/10.3390\/cancers15061897","journal-title":"Cancers"},{"issue":"2","key":"11217_CR218","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3390\/cells9020346","volume":"9","author":"F Triana-Mart\u00ednez","year":"2020","unstructured":"Triana-Mart\u00ednez, F., Loza, M. I., & Dom\u00ednguez, E. (2020). Beyond tumor suppression: Senescence in cancer stemness and tumor dormancy. Cells, 9(2), 346. https:\/\/doi.org\/10.3390\/cells9020346","journal-title":"Cells"},{"key":"11217_CR219","doi-asserted-by":"publisher","unstructured":"Chen, W., Dong, J., Haiech, J., Kilhoffer, M.-C., & Zeniou, M. (2016). Cancer stem cell quiescence and plasticity as major challenges in cancer therapy. Stem Cells International, 2016(1). https:\/\/doi.org\/10.1155\/2016\/1740936","DOI":"10.1155\/2016\/1740936"},{"key":"11217_CR220","doi-asserted-by":"publisher","unstructured":"Dou, J., Jiang, C., Wang, J., Zhang, X., Zhao, F., Hu, W., \u2026 Gu, N. (2011). Using ABCG2-molecule-expressing side population cells to identify cancer stem-like cells in a human ovarian cell line. Cell Biology International, 35(3), 227\u2013234. https:\/\/doi.org\/10.1042\/CBI20100347","DOI":"10.1042\/CBI20100347"},{"issue":"1","key":"11217_CR221","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1475-2867-9-3","volume":"9","author":"K Leelawat","year":"2009","unstructured":"Leelawat, K., Narong, S., Udomchaiprasertkul, W., Leelawat, S., & Tungpradubkul, S. (2009). Inhibition of PI3K increases oxaliplatin sensitivity in cholangiocarcinoma cells. Cancer Cell International, 9(1), 3. https:\/\/doi.org\/10.1186\/1475-2867-9-3","journal-title":"Cancer Cell International"},{"issue":"11","key":"11217_CR222","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18112362","volume":"18","author":"R-R Begicevic","year":"2017","unstructured":"Begicevic, R.-R., & Falasca, M. (2017). ABC transporters in cancer stem cells: Beyond chemoresistance. International Journal of Molecular Sciences, 18(11), Article 2362. https:\/\/doi.org\/10.3390\/ijms18112362","journal-title":"International Journal of Molecular Sciences"},{"issue":"8","key":"11217_CR223","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/sj.bjc.6605626","volume":"102","author":"L Hu","year":"2010","unstructured":"Hu, L., McArthur, C., & Jaffe, R. B. (2010). Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant. British Journal of Cancer, 102(8), 1276\u20131283. https:\/\/doi.org\/10.1038\/sj.bjc.6605626","journal-title":"British Journal of Cancer"},{"issue":"1","key":"11217_CR224","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev.physiol.67.040403.103635","volume":"67","author":"D K\u00fcltz","year":"2005","unstructured":"K\u00fcltz, D. (2005). Molecular and evolutionary basis of the cellular stress response. Annual Review of Physiology, 67(1), 225\u2013257. https:\/\/doi.org\/10.1146\/annurev.physiol.67.040403.103635","journal-title":"Annual Review of Physiology"},{"issue":"5","key":"11217_CR225","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1091\/mbc.e03-11-0799","volume":"15","author":"JI Murray","year":"2004","unstructured":"Murray, J. I., Whitfield, M. L., Trinklein, N. D., Myers, R. M., Brown, P. O., & Botstein, D. (2004). Diverse and specific gene expression responses to stresses in cultured human cells. Molecular Biology of the Cell, 15(5), 2361\u20132374. https:\/\/doi.org\/10.1091\/mbc.e03-11-0799","journal-title":"Molecular Biology of the Cell"},{"key":"11217_CR226","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2025.08.002","author":"D Ho-Tieng","year":"2025","unstructured":"Ho-Tieng, D., Sharma, V., Sonenberg, N., Gkogkas, C. G., & Khoutorsky, A. (2025). The integrated stress response in the brain: Cell type-specific functions in health and neurological disorders. Trends in Neurosciences. https:\/\/doi.org\/10.1016\/j.tins.2025.08.002","journal-title":"Trends in Neurosciences"},{"issue":"33","key":"11217_CR227","doi-asserted-by":"publisher","first-page":"54010","DOI":"10.18632\/oncotarget.9833","volume":"7","author":"Y Yang","year":"2016","unstructured":"Yang, Y., Cheung, H. H., Tu, J., Miu, K. K., & Chan, W. Y. (2016). New insights into the unfolded protein response in stem cells. Oncotarget, 7(33), 54010.","journal-title":"Oncotarget"},{"key":"11217_CR228","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.semcancer.2014.07.001","volume":"31","author":"E Vlashi","year":"2015","unstructured":"Vlashi, E., & Pajonk, F. (2015). Cancer stem cells, cancer cell plasticity and radiation therapy. Seminars in Cancer Biology, 31, 28\u201335. https:\/\/doi.org\/10.1016\/j.semcancer.2014.07.001","journal-title":"Seminars in Cancer Biology"},{"issue":"12","key":"11217_CR229","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nmeth.2688","volume":"10","author":"JD Buenrostro","year":"2013","unstructured":"Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y., & Greenleaf, W. J. (2013). Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nature Methods, 10(12), 1213\u20131218. https:\/\/doi.org\/10.1038\/nmeth.2688","journal-title":"Nature Methods"},{"key":"11217_CR230","doi-asserted-by":"publisher","unstructured":"Martin, E. W., Rodriguez y Baena, A., Reggiardo, R. E., Worthington, A. K., Mattingly, C. S., Poscablo, D. M., \u2026 Forsberg, E. C. (2023). Dynamics of chromatin accessibility during hematopoietic stem cell differentiation into progressively lineage-committed progeny. Stem Cells, 41(5), 520\u2013539. https:\/\/doi.org\/10.1093\/stmcls\/sxad022","DOI":"10.1093\/stmcls\/sxad022"},{"key":"11217_CR231","doi-asserted-by":"publisher","unstructured":"Bonev, B., Mendelson Cohen, N., Szabo, Q., Fritsch, L., Papadopoulos, G. L., Lubling, Y., \u2026 Cavalli, G. (2017). Multiscale 3D genome rewiring during mouse neural development. Cell, 171(3), 557\u2013572.e24. https:\/\/doi.org\/10.1016\/j.cell.2017.09.043","DOI":"10.1016\/j.cell.2017.09.043"},{"key":"11217_CR232","doi-asserted-by":"publisher","unstructured":"Dixon, J. R., Jung, I., Selvaraj, S., Shen, Y., Antosiewicz-Bourget, J. E., Lee, A. Y., \u2026 Ren, B. (2015). Chromatin architecture reorganization during stem cell differentiation. Nature, 518(7539), 331\u2013336. https:\/\/doi.org\/10.1038\/nature14222","DOI":"10.1038\/nature14222"},{"key":"11217_CR233","doi-asserted-by":"publisher","unstructured":"Meissner, A., Mikkelsen, T. S., Gu, H., Wernig, M., Hanna, J., Sivachenko, A., \u2026 Lander, E. S. (2008). Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature, 454(7205), 766\u2013770. https:\/\/doi.org\/10.1038\/nature07107","DOI":"10.1038\/nature07107"},{"key":"11217_CR234","doi-asserted-by":"publisher","unstructured":"Bae, W., Ra, E. A., & Lee, M. H. (2025). Epigenetic regulation of reprogramming and pluripotency: insights from histone modifications and their implications for cancer stem cell therapies. Frontiers in Cell and Developmental Biology, 13. https:\/\/doi.org\/10.3389\/fcell.2025.1559183","DOI":"10.3389\/fcell.2025.1559183"},{"key":"11217_CR235","doi-asserted-by":"publisher","unstructured":"Wang, Y., Frederick, J., Medina, K. I., Bartom, E. T., Almassalha, L. M., Zhang, Y., \u2026 Matei, D. (2025). Chromatin organization governs transcriptional response and plasticity of cancer stem cells. Advanced Science, 12(17). https:\/\/doi.org\/10.1002\/advs.202407426","DOI":"10.1002\/advs.202407426"},{"key":"11217_CR236","doi-asserted-by":"publisher","unstructured":"Verona, F., Pantina, V. D., Modica, C., Lo Iacono, M., D\u2019Accardo, C., Porcelli, G., \u2026 Stassi, G. (2022). Targeting epigenetic alterations in cancer stem cells. Frontiers in Molecular Medicine, 2. https:\/\/doi.org\/10.3389\/fmmed.2022.1011882","DOI":"10.3389\/fmmed.2022.1011882"},{"issue":"6","key":"11217_CR237","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s13238-020-00819-2","volume":"12","author":"Y Feng","year":"2021","unstructured":"Feng, Y., Liu, X., & Pauklin, S. (2021). 3D chromatin architecture and epigenetic regulation in cancer stem cells. Protein & Cell, 12(6), 440\u2013454. https:\/\/doi.org\/10.1007\/s13238-020-00819-2","journal-title":"Protein & Cell"},{"key":"11217_CR238","doi-asserted-by":"publisher","unstructured":"Liau, B. B., Sievers, C., Donohue, L. K., Gillespie, S. M., Flavahan, W. A., Miller, T. E., \u2026 Bernstein, B. E. (2017). Adaptive chromatin remodeling drives glioblastoma stem cell plasticity and drug tolerance. Cell Stem Cell, 20(2), 233\u2013246.e7. https:\/\/doi.org\/10.1016\/j.stem.2016.11.003","DOI":"10.1016\/j.stem.2016.11.003"},{"key":"11217_CR239","doi-asserted-by":"publisher","unstructured":"Llewellyn, J., Baratam, R., Culig, L., & Beerman, I. (2024). Cellular stress and epigenetic regulation in adult stem cells. Life Science Alliance, 7(12), e202302083. https:\/\/doi.org\/10.26508\/lsa.202302083","DOI":"10.26508\/lsa.202302083"},{"key":"11217_CR240","doi-asserted-by":"publisher","unstructured":"Ng, C. X., Lee, S. Y., Yap, X. Y., Wong, Y. H., Loh, J. S., Ang, K. P., \u2026 Lee, S. H. (2025). Epigenetic reprogramming as the nexus of cancer stemness and therapy resistance: implications for biomarker discovery. Discover Oncology. https:\/\/doi.org\/10.1007\/s12672-025-04085-8","DOI":"10.1007\/s12672-025-04085-8"},{"issue":"1","key":"11217_CR241","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13148-021-01107-4","volume":"13","author":"S Keyvani-Ghamsari","year":"2021","unstructured":"Keyvani-Ghamsari, S., Khorsandi, K., Rasul, A., & Zaman, M. K. (2021). Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance. Clinical Epigenetics, 13(1), 120. https:\/\/doi.org\/10.1186\/s13148-021-01107-4","journal-title":"Clinical Epigenetics"},{"issue":"9","key":"11217_CR242","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3390\/cells11091403","volume":"11","author":"VE Kumar","year":"2022","unstructured":"Kumar, V. E., Nambiar, R., De Souza, C., Nguyen, A., Chien, J., & Lam, K. S. (2022). Targeting epigenetic modifiers of tumor plasticity and cancer stem cell behavior. Cells, 11(9), 1403. https:\/\/doi.org\/10.3390\/cells11091403","journal-title":"Cells"},{"key":"11217_CR243","doi-asserted-by":"publisher","unstructured":"Ma, H., Qu, J., Pang, Z., Luo, J., Yan, M., Xu, W., \u2026 Qu, Q. (2024). Super-enhancer omics in stem cell. Molecular Cancer, 23(1), 153. https:\/\/doi.org\/10.1186\/s12943-024-02066-z","DOI":"10.1186\/s12943-024-02066-z"},{"key":"11217_CR244","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.168375","author":"J Chen","year":"2023","unstructured":"Chen, J., Xu, Z., Huang, H., Tang, Y., Shan, H., & Xiao, F. (2023). SETD1A drives stemness by reprogramming the epigenetic landscape in hepatocellular carcinoma stem cells. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.168375","journal-title":"JCI Insight"},{"key":"11217_CR245","doi-asserted-by":"publisher","unstructured":"Boumahdi, S., Driessens, G., Lapouge, G., Rorive, S., Nassar, D., Le Mercier, M., \u2026 Blanpain, C. (2014). SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma. Nature, 511(7508), 246\u2013250. https:\/\/doi.org\/10.1038\/nature13305","DOI":"10.1038\/nature13305"},{"issue":"3","key":"11217_CR246","doi-asserted-by":"publisher","first-page":"270","DOI":"10.5732\/cjc.009.10694","volume":"29","author":"T Chen","year":"2010","unstructured":"Chen, T., Zhang, Y., Guo, W.-H., Meng, M.-B., Mo, X.-M., & Lu, Y. (2010). Effects of heterochromatin in colorectal cancer stem cells on radiosensitivity. Chinese Journal of Cancer, 29(3), 270\u2013276. https:\/\/doi.org\/10.5732\/cjc.009.10694","journal-title":"Chinese Journal of Cancer"},{"key":"11217_CR247","doi-asserted-by":"publisher","unstructured":"Liu, L., Cheung, T. H., Charville, G. W., Hurgo, B. M. C., Leavitt, T., Shih, J., \u2026 Rando, T. A. (2013). Chromatin modifications as determinants of muscle stem cell quiescence and chronological aging. Cell Reports, 4(1), 189\u2013204. https:\/\/doi.org\/10.1016\/j.celrep.2013.05.043","DOI":"10.1016\/j.celrep.2013.05.043"},{"issue":"4","key":"11217_CR248","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.stem.2009.08.016","volume":"5","author":"JJ Trowbridge","year":"2009","unstructured":"Trowbridge, J. J., Snow, J. W., Kim, J., & Orkin, S. H. (2009). DNA methyltransferase 1 is essential for and uniquely regulates hematopoietic stem and progenitor cells. Cell Stem Cell, 5(4), 442\u2013449.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"11217_CR249","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1038\/s41467-021-24137-1","volume":"12","author":"J Dong","year":"2021","unstructured":"Dong, J., Li, J., Li, Y., Ma, Z., Yu, Y., & Wang, C.-Y. (2021). Transcriptional super-enhancers control cancer stemness and metastasis genes in squamous cell carcinoma. Nature Communications, 12(1), 3974. https:\/\/doi.org\/10.1038\/s41467-021-24137-1","journal-title":"Nature Communications"},{"key":"11217_CR250","doi-asserted-by":"publisher","unstructured":"Efroni, S., Duttagupta, R., Cheng, J., Dehghani, H., Hoeppner, D. J., Dash, C., \u2026 Meshorer, E. (2008). Global transcription in pluripotent embryonic stem cells. Cell Stem Cell, 2(5), 437\u2013447. https:\/\/doi.org\/10.1016\/j.stem.2008.03.021","DOI":"10.1016\/j.stem.2008.03.021"},{"key":"11217_CR251","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adu4523","author":"P Rigo","year":"2025","unstructured":"Rigo, P., Ahmed-de-Prado, S., Johnston, R. L., Choudhury, C., Guillemot, F., & Harris, L. (2025). Sequential transcriptional programs underpin activation of hippocampal stem cells. Science Advances. https:\/\/doi.org\/10.1126\/sciadv.adu4523","journal-title":"Science Advances"},{"key":"11217_CR252","doi-asserted-by":"publisher","unstructured":"Lov\u00e9n, J., Hoke, H. A., Lin, C. Y., Lau, A., Orlando, D. A., Vakoc, C. R., \u2026 Young, R. A. (2013). Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell, 153(2), 320\u2013334. https:\/\/doi.org\/10.1016\/j.cell.2013.03.036","DOI":"10.1016\/j.cell.2013.03.036"},{"key":"11217_CR253","doi-asserted-by":"publisher","unstructured":"Adam, R. C., Yang, H., Rockowitz, S., Larsen, S. B., Nikolova, M., Oristian, D. S., \u2026 Fuchs, E. (2015). Pioneer factors govern super-enhancer dynamics in stem cell plasticity and lineage choice. Nature, 521(7552), 366\u2013370. https:\/\/doi.org\/10.1038\/nature14289","DOI":"10.1038\/nature14289"},{"issue":"3","key":"11217_CR254","doi-asserted-by":"publisher","first-page":"720","DOI":"10.4143\/crt.2023.468","volume":"55","author":"H-Y Min","year":"2023","unstructured":"Min, H.-Y., & Lee, H.-Y. (2023). Cellular dormancy in cancer: Mechanisms and potential targeting strategies. Cancer Research and Treatment, 55(3), 720\u2013736. https:\/\/doi.org\/10.4143\/crt.2023.468","journal-title":"Cancer Research and Treatment"},{"key":"11217_CR255","doi-asserted-by":"crossref","unstructured":"Wei, Y., Chen, Q., Huang, S., Liu, Y., Li, Y., Xing, Y., \u2026 Ji, Z. (2022). The interaction between DNMT1 and high\u2010mannose CD133 maintains the slow\u2010cycling state and tumorigenic potential of glioma stem cell. Advanced Science, 9(26), 2202216.","DOI":"10.1002\/advs.202202216"},{"key":"11217_CR256","doi-asserted-by":"publisher","unstructured":"Nakajima, R., Zhao, L., Zhou, Y., Shirasawa, M., Uchida, A., Murakawa, H., \u2026 Ohtani, K. (2023). Deregulated E2F activity as a cancer-cell specific therapeutic tool. Genes, 14(2), 393. https:\/\/doi.org\/10.3390\/genes14020393","DOI":"10.3390\/genes14020393"},{"issue":"6","key":"11217_CR257","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrm3591","volume":"14","author":"TH Cheung","year":"2013","unstructured":"Cheung, T. H., & Rando, T. A. (2013). Molecular regulation of stem cell quiescence. Nature Reviews Molecular Cell Biology, 14(6), 329\u2013340. https:\/\/doi.org\/10.1038\/nrm3591","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"11217_CR258","doi-asserted-by":"publisher","unstructured":"Fong, B. C., Chakroun, I., Iqbal, M. A., Paul, S., Bastasic, J., O\u2019Neil, D., \u2026 Slack, R. S. (2022). The Rb\/E2F axis is a key regulator of the molecular signatures instructing the quiescent and activated adult neural stem cell state. Cell Reports, 41(5), 111578. https:\/\/doi.org\/10.1016\/j.celrep.2022.111578","DOI":"10.1016\/j.celrep.2022.111578"},{"issue":"8","key":"11217_CR259","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.3390\/biomedicines13082039","volume":"13","author":"A Drysch","year":"2025","unstructured":"Drysch, A., Ahuja, A., Prasad, D., Jain, R., Romanos, S., Alwakeal, A., & Ahuja, C. (2025). Transcriptomic comparisons of somatic and cancer stem cells. Biomedicines, 13(8), 2039. https:\/\/doi.org\/10.3390\/biomedicines13082039","journal-title":"Biomedicines"},{"key":"11217_CR260","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.semcancer.2018.11.006","volume":"53","author":"TB Steinbichler","year":"2018","unstructured":"Steinbichler, T. B., Dud\u00e1s, J., Skvortsov, S., Ganswindt, U., Riechelmann, H., & Skvortsova, I.-I. (2018). Therapy resistance mediated by cancer stem cells. Seminars in Cancer Biology, 53, 156\u2013167. https:\/\/doi.org\/10.1016\/j.semcancer.2018.11.006","journal-title":"Seminars in Cancer Biology"},{"issue":"5","key":"11217_CR261","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.gpb.2013.09.006","volume":"11","author":"M Zhang","year":"2013","unstructured":"Zhang, M., Yang, C., Liu, H., & Sun, Y. (2013). Induced pluripotent stem cells are sensitive to DNA damage. Genomics, Proteomics & Bioinformatics, 11(5), 320\u2013326. https:\/\/doi.org\/10.1016\/j.gpb.2013.09.006","journal-title":"Genomics, Proteomics & Bioinformatics"},{"key":"11217_CR262","doi-asserted-by":"publisher","unstructured":"Turdo, A., Gaggianesi, M., Di Franco, S., Veschi, V., D\u2019Accardo, C., Porcelli, G., \u2026 Todaro, M. (2022). Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51. Oncogene, 41(15), 2196\u20132209. https:\/\/doi.org\/10.1038\/s41388-022-02239-4","DOI":"10.1038\/s41388-022-02239-4"},{"key":"11217_CR263","doi-asserted-by":"publisher","unstructured":"Gillespie, M. S., Chiang, K., Regan-Mochrie, G. L., Choi, S.-Y., Ward, C. M., Sahay, D., \u2026 Davies, C. C. (2025). PRMT5-regulated splicing of DNA repair genes drives chemoresistance in breast cancer stem cells. Oncogene, 44(13), 862\u2013876. https:\/\/doi.org\/10.1038\/s41388-024-03264-1","DOI":"10.1038\/s41388-024-03264-1"},{"issue":"8","key":"11217_CR264","doi-asserted-by":"publisher","first-page":"e1360","DOI":"10.1038\/cddis.2014.326","volume":"5","author":"P Meng","year":"2014","unstructured":"Meng, P., & Ghosh, R. (2014). Transcription addiction: Can we garner the Yin and Yang functions of E2F1 for cancer therapy? Cell Death & Disease, 5(8), e1360\u2013e1360. https:\/\/doi.org\/10.1038\/cddis.2014.326","journal-title":"Cell Death & Disease"},{"key":"11217_CR265","doi-asserted-by":"publisher","unstructured":"Shats, I., Deng, M., Davidovich, A., Zhang, C., Kwon, J. S., Manandhar, D., \u2026 You, L. (2017). Expression level is a key determinant of E2F1-mediated cell fate. Cell Death & Differentiation, 24(4), 626\u2013637. https:\/\/doi.org\/10.1038\/cdd.2017.12","DOI":"10.1038\/cdd.2017.12"},{"key":"11217_CR266","doi-asserted-by":"publisher","unstructured":"Zhang, S., Duan, S., Xie, Z., Bao, W., Xu, B., Yang, W., & Zhou, L. (2022). Epigenetic therapeutics targeting NRF2\/KEAP1 signaling in cancer oxidative stress. Frontiers in Pharmacology, 13. https:\/\/doi.org\/10.3389\/fphar.2022.924817","DOI":"10.3389\/fphar.2022.924817"},{"key":"11217_CR267","doi-asserted-by":"publisher","unstructured":"Rosenfeldt, M. T., Bell, L. A., Long, J. S., O\u2019Prey, J., Nixon, C., Roberts, F., \u2026 Ryan, K. M. (2014). E2F1 drives chemotherapeutic drug resistance via ABCG2. Oncogene, 33(32), 4164\u20134172. https:\/\/doi.org\/10.1038\/onc.2013.470","DOI":"10.1038\/onc.2013.470"},{"key":"11217_CR268","doi-asserted-by":"publisher","unstructured":"Mun, J.-Y., Baek, S.-W., Park, W. Y., Kim, W.-T., Kim, S.-K., Roh, Y.-G., \u2026 Leem, S.-H. (2020). E2F1 promotes progression of bladder cancer by modulating RAD54L involved in homologous recombination repair. International Journal of Molecular Sciences, 21(23), 9025. https:\/\/doi.org\/10.3390\/ijms21239025","DOI":"10.3390\/ijms21239025"},{"key":"11217_CR269","doi-asserted-by":"publisher","unstructured":"Xie, Q., Peng, S., Tao, L., Ruan, H., Yang, Y., Li, T.-M., \u2026 Yuan, Z. (2014). E2F transcription factor 1 regulates cellular and organismal senescence by inhibiting forkhead box o transcription factors. Journal of Biological Chemistry, 289(49), 34205\u201334213. https:\/\/doi.org\/10.1074\/jbc.M114.587170","DOI":"10.1074\/jbc.M114.587170"},{"key":"11217_CR270","doi-asserted-by":"publisher","unstructured":"Lu, K., Alcivar, A. L., Ma, J., Foo, T. K., Zywea, S., Mahdi, A., \u2026 Xia, B. (2017). NRF2 Induction supporting breast cancer cell survival is enabled by oxidative stress\u2013induced DPP3\u2013KEAP1 interaction. Cancer Research, 77(11), 2881\u20132892. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2204","DOI":"10.1158\/0008-5472.CAN-16-2204"},{"key":"11217_CR271","doi-asserted-by":"publisher","unstructured":"Li, C., Wu, S., Yang, Z., Zhang, X., Zheng, Q., Lin, L., \u2026 Li, L. (2017). Single-cell exome sequencing identifies mutations in KCP, LOC440040, and LOC440563 as drivers in renal cell carcinoma stem cells. Cell Research, 27(4), 590\u2013593. https:\/\/doi.org\/10.1038\/cr.2016.150","DOI":"10.1038\/cr.2016.150"},{"key":"11217_CR272","doi-asserted-by":"publisher","unstructured":"Marei, H. E., Althani, A., Afifi, N., Hasan, A., Caceci, T., Felsani, A., \u2026 Cenciarelli, C. (2022). Exome sequencing of glioblastoma-derived cancer stem cells reveals rare clinically relevant frameshift deletion in MLLT1 gene. Cancer Cell International, 22(1), 9. https:\/\/doi.org\/10.1186\/s12935-021-02419-4","DOI":"10.1186\/s12935-021-02419-4"},{"key":"11217_CR273","doi-asserted-by":"publisher","unstructured":"De Angelis, M. L., Zeuner, A., Policicchio, E., Russo, G., Bruselles, A., Signore, M., \u2026 Baiocchi, M. (2016). Cancer stem cell-based models of colorectal cancer reveal molecular determinants of therapy resistance. Stem Cells Translational Medicine, 5(4), 511\u2013523. https:\/\/doi.org\/10.5966\/sctm.2015-0214","DOI":"10.5966\/sctm.2015-0214"},{"issue":"1","key":"11217_CR274","doi-asserted-by":"publisher","first-page":"12742","DOI":"10.1038\/s41598-023-39608-2","volume":"13","author":"M Sinkala","year":"2023","unstructured":"Sinkala, M. (2023). Mutational landscape of cancer-driver genes across human cancers. Scientific Reports, 13(1), 12742. https:\/\/doi.org\/10.1038\/s41598-023-39608-2","journal-title":"Scientific Reports"},{"issue":"1","key":"11217_CR275","doi-asserted-by":"publisher","first-page":"5961","DOI":"10.1038\/s41467-021-26213-y","volume":"12","author":"G Mendiratta","year":"2021","unstructured":"Mendiratta, G., Ke, E., Aziz, M., Liarakos, D., Tong, M., & Stites, E. C. (2021). Cancer gene mutation frequencies for the U.S. population. Nature Communications, 12(1), 5961. https:\/\/doi.org\/10.1038\/s41467-021-26213-y","journal-title":"Nature Communications"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11217-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-026-11217-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11217-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:02:46Z","timestamp":1793300566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-026-11217-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":275,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["11217"],"URL":"https:\/\/doi.org\/10.1007\/s12015-026-11217-2","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}